Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	calcium ion binding	CDHR2 NBPF26 DYSF RYR3 ITPR2 FAT1 NOTCH3 FAT4 PCDHGC4 PCDHGA4 PCDHB15 PCDHB14 PCDHB13 PCDHB12 PCDHB11 PCDHB10 PCDHB9 PCDHB8 PCDHB7 PCDHB3 PCDHB16 USP6 EYS CDH22 DSG4 MCTP2 CDH4 CDH13	3.32e-07	749	253	28	GO:0005509
GeneOntologyBiologicalProcess	homophilic cell adhesion via plasma membrane adhesion molecules	CEACAM5 CDHR2 FAT1 ROBO4 FAT4 PCDHGC4 PCDHGA4 PCDHB15 PCDHB14 PCDHB13 PCDHB12 PCDHB11 PCDHB10 PCDHB9 PCDHB8 PCDHB7 PCDHB3 PCDHB16 CDH22 DSG4 CDH4 CDH13	1.00e-15	187	249	22	GO:0007156
GeneOntologyBiologicalProcess	cell-cell adhesion via plasma-membrane adhesion molecules	CEACAM5 CDHR2 JAML FAT1 LRFN4 ROBO4 FAT4 PCDHGC4 PCDHGA4 PCDHB15 PCDHB14 PCDHB13 PCDHB12 PCDHB11 PCDHB10 PCDHB9 PCDHB8 PCDHB7 PCDHB3 PCDHB16 CDH22 CRTAM DSG4 CDH4 CDH13	9.12e-14	313	249	25	GO:0098742
GeneOntologyBiologicalProcess	calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules	PCDHB14 PCDHB13 PCDHB11 PCDHB10 PCDHB9 PCDHB8 PCDHB3 PCDHB16 CDH22 CDH4 CDH13	3.10e-11	53	249	11	GO:0016339
GeneOntologyBiologicalProcess	cell-cell adhesion	CFH ERBB2 CEACAM5 ABL1 CDHR2 ITGA2B JAML NOD2 FAT1 LRFN4 IL23R ROBO4 TNFAIP8L2 FAT4 PCDHGC4 PCDHGA4 PCDHB15 PCDHB14 PCDHB13 PCDHB12 PCDHB11 CAMSAP3 PCDHB10 PCDHB9 PCDHB8 PCDHB7 PCDHB3 NR4A3 PCDHB16 GSTP1 CDH22 TNFSF11 CRTAM SMARCC1 SMARCC2 LRP5 DSG4 SCRIB CDH4 CDH13	2.13e-10	1077	249	40	GO:0098609
GeneOntologyBiologicalProcess	establishment of cell polarity	ABL1 MAP1B MYO9B FAT1 PLK1 MOS MCPH1 CAMSAP3 CRTAM SCRIB ARHGEF2 PATJ	1.71e-06	177	249	12	GO:0030010
GeneOntologyBiologicalProcess	establishment or maintenance of cell polarity	ABL1 MAP1B MYO9B FAT1 PLK1 MOS CAP1 MCPH1 CAMSAP3 CRTAM SCRIB ARHGEF2 PATJ	1.57e-05	257	249	13	GO:0007163
GeneOntologyBiologicalProcess	establishment of monopolar cell polarity	MAP1B FAT1 CAMSAP3 SCRIB PATJ	1.93e-05	28	249	5	GO:0061162
GeneOntologyBiologicalProcess	establishment or maintenance of monopolar cell polarity	MAP1B FAT1 CAMSAP3 SCRIB PATJ	2.31e-05	29	249	5	GO:0061339
GeneOntologyBiologicalProcess	cell junction organization	ERBB2 CEACAM5 ABL1 MAP1B MPDZ EPB41L3 LRFN4 CLN3 CAP1 PCDHGC4 DLGAP4 PCDHB14 PCDHB13 PCDHB11 CAMSAP3 PCDHB10 PCDHB9 PCDHB8 PCDHB3 PCDHB16 CDH22 SIPA1L1 LRP5 PATJ CDH4 CDH13 SEZ6L	5.25e-05	974	249	27	GO:0034330
GeneOntologyBiologicalProcess	protein-containing complex disassembly	MAP1B JMJD4 DYSF CLN3 SVIL DDIT4 CHMP5 CAMSAP3 SNX14 SMARCC1 SMARCC2 ARHGEF2 SMCR8	5.72e-05	291	249	13	GO:0032984
GeneOntologyBiologicalProcess	cell junction assembly	ABL1 MAP1B MPDZ EPB41L3 LRFN4 PCDHB14 PCDHB13 PCDHB11 CAMSAP3 PCDHB10 PCDHB9 PCDHB8 PCDHB3 PCDHB16 CDH22 SIPA1L1 PATJ CDH4 CDH13	6.70e-05	569	249	19	GO:0034329
GeneOntologyBiologicalProcess	DNA-templated DNA replication maintenance of fidelity	ATR BRCA1 POLD1 CAMSAP3 FANCM POLQ	8.46e-05	60	249	6	GO:0045005
GeneOntologyBiologicalProcess	synaptic signaling	DLGAP2 ABL1 MAP1B HTR3C DYSF CLN3 LILRB5 CA2 FCHSD1 AMPH VPS18 DLGAP4 PCDHB14 PCDHB13 PCDHB11 PCDHB10 PCDHB9 PCDHB8 PCDHB3 PCDHB16 ORAI1 SNX14 SIPA1L1 MTNR1B SCRIB MCTP2	1.38e-04	976	249	26	GO:0099536
GeneOntologyBiologicalProcess	cellular response to muramyl dipeptide	NOD2 CHMP5 ARHGEF2	1.38e-04	9	249	3	GO:0071225
GeneOntologyBiologicalProcess	double-strand break repair via alternative nonhomologous end joining	PLK1 HELQ POLQ	1.38e-04	9	249	3	GO:0097681
GeneOntologyBiologicalProcess	negative regulation of early endosome to late endosome transport	SNX3 SNX12	1.45e-04	2	249	2	GO:2000642
GeneOntologyBiologicalProcess	regulation of actin binding	ABL1 TNFSF11	1.45e-04	2	249	2	GO:1904616
GeneOntologyBiologicalProcess	anterograde trans-synaptic signaling	DLGAP2 ABL1 MAP1B HTR3C DYSF CLN3 LILRB5 CA2 FCHSD1 AMPH VPS18 DLGAP4 PCDHB14 PCDHB13 PCDHB11 PCDHB10 PCDHB9 PCDHB8 PCDHB3 PCDHB16 SNX14 SIPA1L1 MTNR1B SCRIB MCTP2	1.65e-04	931	249	25	GO:0098916
GeneOntologyBiologicalProcess	chemical synaptic transmission	DLGAP2 ABL1 MAP1B HTR3C DYSF CLN3 LILRB5 CA2 FCHSD1 AMPH VPS18 DLGAP4 PCDHB14 PCDHB13 PCDHB11 PCDHB10 PCDHB9 PCDHB8 PCDHB3 PCDHB16 SNX14 SIPA1L1 MTNR1B SCRIB MCTP2	1.65e-04	931	249	25	GO:0007268
GeneOntologyBiologicalProcess	trans-synaptic signaling	DLGAP2 ABL1 MAP1B HTR3C DYSF CLN3 LILRB5 CA2 FCHSD1 AMPH VPS18 DLGAP4 PCDHB14 PCDHB13 PCDHB11 PCDHB10 PCDHB9 PCDHB8 PCDHB3 PCDHB16 SNX14 SIPA1L1 MTNR1B SCRIB MCTP2	1.88e-04	939	249	25	GO:0099537
GeneOntologyBiologicalProcess	cellular component disassembly	ATR MAP1B SREBF1 JMJD4 DYSF NOD2 TEX264 CLN3 SVIL PLK1 DDIT4 CHMP5 CAMSAP3 SNX14 SHARPIN SMARCC1 SMARCC2 ARHGEF2 SMCR8	1.91e-04	617	249	19	GO:0022411
GeneOntologyBiologicalProcess	regulation of microtubule-based process	ERBB2 ABL1 MAP1B DYSF BRCA1 PLK1 MCPH1 CHMP5 CAMSAP3 CEP192 GDA ARHGEF2	2.47e-04	293	249	12	GO:0032886
GeneOntologyBiologicalProcess	establishment of apical/basal cell polarity	FAT1 CAMSAP3 SCRIB PATJ	2.51e-04	26	249	4	GO:0035089
Domain	Cadherin_CS	CDHR2 FAT1 FAT4 PCDHGC4 PCDHGA4 PCDHB15 PCDHB14 PCDHB13 PCDHB12 PCDHB11 PCDHB10 PCDHB9 PCDHB8 PCDHB7 PCDHB3 PCDHB16 CDH22 DSG4 CDH4 CDH13	3.41e-17	109	257	20	IPR020894
Domain	CADHERIN_1	CDHR2 FAT1 FAT4 PCDHGC4 PCDHGA4 PCDHB15 PCDHB14 PCDHB13 PCDHB12 PCDHB11 PCDHB10 PCDHB9 PCDHB8 PCDHB7 PCDHB3 PCDHB16 CDH22 DSG4 CDH4 CDH13	7.15e-17	113	257	20	PS00232
Domain	Cadherin	CDHR2 FAT1 FAT4 PCDHGC4 PCDHGA4 PCDHB15 PCDHB14 PCDHB13 PCDHB12 PCDHB11 PCDHB10 PCDHB9 PCDHB8 PCDHB7 PCDHB3 PCDHB16 CDH22 DSG4 CDH4 CDH13	7.15e-17	113	257	20	PF00028
Domain	CADHERIN_2	CDHR2 FAT1 FAT4 PCDHGC4 PCDHGA4 PCDHB15 PCDHB14 PCDHB13 PCDHB12 PCDHB11 PCDHB10 PCDHB9 PCDHB8 PCDHB7 PCDHB3 PCDHB16 CDH22 DSG4 CDH4 CDH13	8.57e-17	114	257	20	PS50268
Domain	-	CDHR2 FAT1 FAT4 PCDHGC4 PCDHGA4 PCDHB15 PCDHB14 PCDHB13 PCDHB12 PCDHB11 PCDHB10 PCDHB9 PCDHB8 PCDHB7 PCDHB3 PCDHB16 CDH22 DSG4 CDH4 CDH13	8.57e-17	114	257	20	2.60.40.60
Domain	CA	CDHR2 FAT1 FAT4 PCDHGC4 PCDHGA4 PCDHB15 PCDHB14 PCDHB13 PCDHB12 PCDHB11 PCDHB10 PCDHB9 PCDHB8 PCDHB7 PCDHB3 PCDHB16 CDH22 DSG4 CDH4 CDH13	1.02e-16	115	257	20	SM00112
Domain	Cadherin-like	CDHR2 FAT1 FAT4 PCDHGC4 PCDHGA4 PCDHB15 PCDHB14 PCDHB13 PCDHB12 PCDHB11 PCDHB10 PCDHB9 PCDHB8 PCDHB7 PCDHB3 PCDHB16 CDH22 DSG4 CDH4 CDH13	1.22e-16	116	257	20	IPR015919
Domain	Cadherin	CDHR2 FAT1 FAT4 PCDHGC4 PCDHGA4 PCDHB15 PCDHB14 PCDHB13 PCDHB12 PCDHB11 PCDHB10 PCDHB9 PCDHB8 PCDHB7 PCDHB3 PCDHB16 CDH22 DSG4 CDH4 CDH13	1.73e-16	118	257	20	IPR002126
Domain	Cadherin_C	PCDHGA4 PCDHB15 PCDHB14 PCDHB13 PCDHB12 PCDHB11 PCDHB10 PCDHB9 PCDHB8 PCDHB7 PCDHB3 PCDHB16	2.73e-13	42	257	12	IPR032455
Domain	Cadherin_C_2	PCDHGA4 PCDHB15 PCDHB14 PCDHB13 PCDHB12 PCDHB11 PCDHB10 PCDHB9 PCDHB8 PCDHB7 PCDHB3 PCDHB16	2.73e-13	42	257	12	PF16492
Domain	Cadherin_2	PCDHGC4 PCDHGA4 PCDHB15 PCDHB14 PCDHB13 PCDHB12 PCDHB11 PCDHB10 PCDHB9 PCDHB8 PCDHB7 PCDHB3 PCDHB16	4.07e-12	65	257	13	PF08266
Domain	Cadherin_N	PCDHGC4 PCDHGA4 PCDHB15 PCDHB14 PCDHB13 PCDHB12 PCDHB11 PCDHB10 PCDHB9 PCDHB8 PCDHB7 PCDHB3 PCDHB16	4.07e-12	65	257	13	IPR013164
Domain	LRRC37AB_C	LRRC37A3 LRRC37A2 LRRC37A	1.02e-05	4	257	3	IPR029423
Domain	LRRC37AB_C	LRRC37A3 LRRC37A2 LRRC37A	1.02e-05	4	257	3	PF14914
Domain	LRRC37_N	LRRC37A3 LRRC37A2 LRRC37A	1.02e-05	4	257	3	IPR032754
Domain	LRRC37	LRRC37A3 LRRC37A2 LRRC37A	1.02e-05	4	257	3	PF15779
Domain	LRRC37A/B-like	LRRC37A3 LRRC37A2 LRRC37A	1.02e-05	4	257	3	IPR015753
Domain	L27_2	MPDZ PATJ	1.89e-04	2	257	2	PF09045
Domain	SMARCC_C	SMARCC1 SMARCC2	1.89e-04	2	257	2	IPR032451
Domain	SMARCC_N	SMARCC1 SMARCC2	1.89e-04	2	257	2	IPR032450
Domain	SWIRM-assoc	SMARCC1 SMARCC2	1.89e-04	2	257	2	IPR032448
Domain	L27_2	MPDZ PATJ	1.89e-04	2	257	2	IPR015132
Domain	SWIRM-assoc_2	SMARCC1 SMARCC2	1.89e-04	2	257	2	PF16496
Domain	SWIRM-assoc_1	SMARCC1 SMARCC2	1.89e-04	2	257	2	PF16495
Domain	SWIRM-assoc_3	SMARCC1 SMARCC2	1.89e-04	2	257	2	PF16498
Domain	DUF1220	NBPF14 NBPF15 NBPF9	3.92e-04	11	257	3	PF06758
Domain	NBPF_dom	NBPF14 NBPF15 NBPF9	3.92e-04	11	257	3	IPR010630
Domain	NBPF	NBPF14 NBPF15 NBPF9	3.92e-04	11	257	3	PS51316
Domain	BRCT_dom	BRCA1 MCPH1 SMARCC1 SMARCC2	5.53e-04	28	257	4	IPR001357
Domain	Orai-1	ORAI1 ORAI3	5.61e-04	3	257	2	PF07856
Domain	CRAC_channel	ORAI1 ORAI3	5.61e-04	3	257	2	IPR012446
Domain	Dynein_heavy_chain_D4_dom	DNAH8 DNAH10 DNAH1	8.38e-04	14	257	3	IPR024317
Domain	Dynein_HC_stalk	DNAH8 DNAH10 DNAH1	8.38e-04	14	257	3	IPR024743
Domain	Dynein_heavy_dom-2	DNAH8 DNAH10 DNAH1	8.38e-04	14	257	3	IPR013602
Domain	DHC_N2	DNAH8 DNAH10 DNAH1	8.38e-04	14	257	3	PF08393
Domain	ATPase_dyneun-rel_AAA	DNAH8 DNAH10 DNAH1	8.38e-04	14	257	3	IPR011704
Domain	MT	DNAH8 DNAH10 DNAH1	8.38e-04	14	257	3	PF12777
Domain	AAA_8	DNAH8 DNAH10 DNAH1	8.38e-04	14	257	3	PF12780
Domain	AAA_5	DNAH8 DNAH10 DNAH1	8.38e-04	14	257	3	PF07728
Domain	DHC_fam	DNAH8 DNAH10 DNAH1	1.04e-03	15	257	3	IPR026983
Domain	Dynein_heavy	DNAH8 DNAH10 DNAH1	1.04e-03	15	257	3	PF03028
Domain	Dynein_heavy_dom	DNAH8 DNAH10 DNAH1	1.04e-03	15	257	3	IPR004273
Pubmed	The human and murine protocadherin-beta one-exon gene families show high evolutionary conservation, despite the difference in gene number.	PCDHB15 PCDHB14 PCDHB13 PCDHB12 PCDHB11 PCDHB10 PCDHB9 PCDHB8 PCDHB7 PCDHB3 PCDHB16	7.62e-19	20	269	11	11322959
Pubmed	Comparative DNA sequence analysis of mouse and human protocadherin gene clusters.	PCDHGC4 PCDHGA4 PCDHB15 PCDHB14 PCDHB13 PCDHB12 PCDHB11 PCDHB10 PCDHB9 PCDHB8 PCDHB7 PCDHB3 PCDHB16	5.69e-15	68	269	13	11230163
Pubmed	A striking organization of a large family of human neural cadherin-like cell adhesion genes.	PCDHGC4 PCDHGA4 PCDHB15 PCDHB14 PCDHB13 PCDHB12 PCDHB11 PCDHB10 PCDHB9 PCDHB8 PCDHB7 PCDHB3 PCDHB16	1.25e-14	72	269	13	10380929
Pubmed	Protocadherins.	PCDHB14 PCDHB13 PCDHB11 PCDHB10 PCDHB9 PCDHB8 PCDHB3 PCDHB16	1.44e-14	13	269	8	12231349
Pubmed	Cadherin superfamily genes: functions, genomic organization, and neurologic diversity.	PCDHGC4 PCDHGA4 PCDHB15 PCDHB14 PCDHB13 PCDHB12 PCDHB11 PCDHB10 PCDHB9 PCDHB8 PCDHB7 PCDHB3 PCDHB16	1.82e-14	74	269	13	10817752
Pubmed	Clustered gamma-protocadherins regulate cortical interneuron programmed cell death.	PCDHGA4 PCDHB15 PCDHB14 PCDHB13 PCDHB12 PCDHB11 PCDHB10 PCDHB9 PCDHB8 PCDHB7 PCDHB3 PCDHB16	1.86e-14	57	269	12	32633719
Pubmed	CTCF Governs the Identity and Migration of MGE-Derived Cortical Interneurons.	PCDHGA4 PCDHB15 PCDHB14 PCDHB13 PCDHB12 PCDHB11 PCDHB10 PCDHB9 PCDHB8 PCDHB7 PCDHB3 PCDHB16	2.33e-14	58	269	12	30377227
Pubmed	Phylogenetic analysis of the cadherin superfamily allows identification of six major subfamilies besides several solitary members.	PCDHGC4 PCDHGA4 PCDHB15 PCDHB14 PCDHB13 PCDHB12 PCDHB11 PCDHB10 PCDHB9 PCDHB8 PCDHB7 PCDHB3 PCDHB16	3.14e-14	77	269	13	10835267
Pubmed	Large exons encoding multiple ectodomains are a characteristic feature of protocadherin genes.	PCDHGC4 PCDHGA4 PCDHB15 PCDHB14 PCDHB13 PCDHB12 PCDHB11 PCDHB10 PCDHB9 PCDHB8 PCDHB7 PCDHB3 PCDHB16	5.27e-14	80	269	13	10716726
Pubmed	Single-neuron diversity generated by Protocadherin-β cluster in mouse central and peripheral nervous systems.	PCDHB15 PCDHB13 PCDHB12 PCDHB11 PCDHB8 PCDHB7 PCDHB3	1.80e-13	10	269	7	22969705
Pubmed	A novel gene family NBPF: intricate structure generated by gene duplications during primate evolution.	NBPF19 NBPF14 NBPF8 NBPF20 NBPF15 NBPF9 NBPF10	1.62e-10	21	269	7	16079250
Pubmed	Postsynaptic and differential localization to neuronal subtypes of protocadherin beta16 in the mammalian central nervous system.	PCDHB15 PCDHB13 PCDHB12 PCDHB11 PCDHB8 PCDHB3	2.33e-09	17	269	6	18279309
Pubmed	Systematic identification of SH3 domain-mediated human protein-protein interactions by peptide array target screening.	DLGAP2 SNX3 ABL1 CUL9 EPB41L3 OPTC BRCA1 SNX12 NOTCH3 MOS POLD1 DLGAP4 ASB16 SMARCC1 SMARCC2	5.24e-08	329	269	15	17474147
Pubmed	A unique role of cohesin-SA1 in gene regulation and development.	PCDHB15 PCDHB14 PCDHB13 PCDHB8 PCDHB16	1.09e-07	16	269	5	22415368
Pubmed	Identification of novel cadherins expressed in human melanoma cells.	FAT1 PCDHB14 PCDHB11 PCDHB16	1.20e-07	7	269	4	9182820
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	ERBB2 DCAF6 ZNF219 CUL9 EPB41L3 DDB1 ADCY6 BRWD3 LARP4B ZNF469 FAT1 BRCA1 ZC3H4 NFKBIL1 ADAMTS1 POLD1 PHRF1 LGALS3BP KMT5B SIPA1L1 TBK1 SMARCC1 SMARCC2 SCRIB CLSPN ANKS3 SEZ6L	2.00e-07	1116	269	27	31753913
Pubmed	Evolutionary history and genome organization of DUF1220 protein domains.	NBPF14 NBPF8 NBPF15 NBPF9	7.09e-07	10	269	4	22973535
Pubmed	ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1.	CFH ERBB2 ATR MAP1B SREBF1 NBPF26 DDB1 GTF3C3 DMXL1 ITPR2 FAT1 SVIL TTC13 NOTCH3 FAM234B FAT4 RANBP6 CPD LGALS3BP NUP35 PLA2R1 SNX14 LOX LRP5 SMPD1 SCRIB CDH13	8.29e-07	1201	269	27	35696571
Pubmed	Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.	ATR MAP1B SREBF1 MPDZ ADCY6 FARP2 ZC3H4 STARD3 CAMSAP3 DIS3 CEMIP LPIN3 RPAP1 TBK1 SMARCC1 SCRIB ARHGEF2 CLSPN PATJ	9.15e-07	650	269	19	38777146
Pubmed	Comparative interactome analysis of α-arrestin families in human and Drosophila.	CAND2 MAP1B CUL9 EPB41L3 GTF3C3 FARP2 SVIL NFKBIL1 ADAMTS1 POLD1 CPD SCRIB ARHGEF2	1.17e-06	313	269	13	38270169
Pubmed	Primate segmental duplication creates novel promoters for the LRRC37 gene family within the 17q21.31 inversion polymorphism region.	LRRC37A3 LRRC37A2 LRRC37A	1.82e-06	4	269	3	22419166
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	ERBB2 ABL1 MYO9B SREBF1 CUL9 DYSF ACOX3 ITPR2 NOD2 FAT1 CLN3 NBEAL2 KCNJ11 RANBP10 SH3RF1 MYOM3 TRMT1 CEP192 KCNH3 LPIN3 ORAI1 SEPHS2 RPAP1 LRP5 ARHGEF2	1.93e-06	1105	269	25	35748872
Pubmed	DNA Repair Network Analysis Reveals Shieldin as a Key Regulator of NHEJ and PARP Inhibitor Sensitivity.	ATR GTF3C3 BRCA1 ZC3H4 DGCR8 PLK1 MCPH1 POLD1 CHMP5 FANCM DIS3 LOX SMARCC1 SMARCC2 CDH13	2.96e-06	453	269	15	29656893
Pubmed	Homozygous frameshift mutations in FAT1 cause a syndrome characterized by colobomatous-microphthalmia, ptosis, nephropathy and syndactyly.	FAT1 YAP1 FAT4	4.52e-06	5	269	3	30862798
Pubmed	Association between genetic variants in myosin IXB and Crohn's disease.	MYO9B NOD2 IL23R	4.52e-06	5	269	3	19235913
Pubmed	Epigenetic functions of smchd1 repress gene clusters on the inactive X chromosome and on autosomes.	BRWD3 PCDHB15 PCDHB12 PCDHB11 PCDHB3 PCDHB16	6.47e-06	59	269	6	23754746
Pubmed	BRCA1 is associated with a human SWI/SNF-related complex: linking chromatin remodeling to breast cancer.	BRCA1 SMARCC1 SMARCC2	9.00e-06	6	269	3	10943845
Pubmed	Fat1 interacts with Fat4 to regulate neural tube closure, neural progenitor proliferation and apical constriction during mouse brain development.	MPDZ FAT1 YAP1 FAT4	9.83e-06	18	269	4	26209645
Pubmed	Reduction of Nipbl impairs cohesin loading locally and affects transcription but not cohesion-dependent functions in a mouse model of Cornelia de Lange Syndrome.	PCDHB14 PCDHB13 PCDHB8 PCDHB16	1.24e-05	19	269	4	23920377
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	ERBB2 SNX3 ABL1 MAP1B SEC24A MPDZ EPB41L3 YAP1 SVIL PLK1 USP53 SH3RF1 CAMSAP3 CEP192 LPIN3 SIPA1L1 PLEKHM3 SCRIB ARHGEF2 PATJ	1.46e-05	861	269	20	36931259
Pubmed	BRIT1/MCPH1 links chromatin remodelling to DNA damage response.	MCPH1 SMARCC1 SMARCC2	1.57e-05	7	269	3	19525936
Pubmed	A mouse knockout library for secreted and transmembrane proteins.	HEPACAM2 ITGA2B STEAP2 JAML NBEAL2 FCHSD1 ROBO4 PCDHB13 PCDHB10 PCDHB9 PCDHB8 FAM131A CRTAM SEZ6L	1.63e-05	460	269	14	20562862
Pubmed	mTOR drives its own activation via SCF(βTrCP)-dependent degradation of the mTOR inhibitor DEPTOR.	YAP1 FANCM SIPA1L1 CLSPN	2.76e-05	23	269	4	22017875
Pubmed	Vpr-induced DNA double-strand breaks: molecular mechanism and biological relevance.	ATR DDB1 BRCA1	3.71e-05	9	269	3	19275579
Pubmed	Substrate specificities and identification of putative substrates of ATM kinase family members.	ABL1 ATR BRCA1 POLD1	3.90e-05	25	269	4	10608806
Pubmed	Evolutionary dynamism of the primate LRRC37 gene family.	LRRC37A3 LRRC37A2 LRRC37A	5.27e-05	10	269	3	23064749
Pubmed	New interaction partners for Nek4.1 and Nek4.2 isoforms: from the DNA damage response to RNA splicing.	MAP1B CSMD3 NBPF14 CAP1 NBPF8 FAT4 VPS18 CAMSAP3 LGALS3BP SEPHS2 NBPF15 NBPF9 NBPF10 DSG4	5.34e-05	513	269	14	25798074
Pubmed	CRL4 complex regulates mammalian oocyte survival and reprogramming by activation of TET proteins.	ABL1 GDF9 DDB1 YAP1 MOS	5.65e-05	53	269	5	24357321
Pubmed	Bimodal Interaction of Mammalian Polo-Like Kinase 1 and a Centrosomal Scaffold, Cep192, in the Regulation of Bipolar Spindle Formation.	PLK1 CEP192	5.96e-05	2	269	2	26012549
Pubmed	MPDZ is associated with immune infiltration and regulates migration and invasion by switching YAP1 phosphorylation in colorectal cancer.	MPDZ YAP1	5.96e-05	2	269	2	37949382
Pubmed	Heterozygosity for IL23R p.Arg381Gln confers a protective effect not only against Crohn's disease but also ulcerative colitis.	NOD2 IL23R	5.96e-05	2	269	2	17877509
Pubmed	Plasticity in Ca2+ selectivity of Orai1/Orai3 heteromeric channel.	ORAI1 ORAI3	5.96e-05	2	269	2	19887627
Pubmed	NOD2/CARD15 and IL23R genetic variability in 204 Algerian Crohn's disease.	NOD2 IL23R	5.96e-05	2	269	2	24679666
Pubmed	Circulating Bone-related Markers and YKL-40 Versus HER2 and TOPO2a in Bone Metastatic and Nonmetastatic Breast Cancer: Diagnostic Implications.	ERBB2 TNFSF11	5.96e-05	2	269	2	28645722
Pubmed	655Val and 1170Pro ERBB2 SNPs in familial breast cancer risk and BRCA1 alterations.	ERBB2 BRCA1	5.96e-05	2	269	2	17452776
Pubmed	Differential Redox Regulation of Ca²⁺ Signaling and Viability in Normal and Malignant Prostate Cells.	ORAI1 ORAI3	5.96e-05	2	269	2	26445441
Pubmed	Microcephalin is a new novel prognostic indicator in breast cancer associated with BRCA1 inactivation.	BRCA1 MCPH1	5.96e-05	2	269	2	20632086
Pubmed	The Swi3 protein plays a unique role in regulating respiration in eukaryotes.	SMARCC1 SMARCC2	5.96e-05	2	269	2	27190130
Pubmed	Human Claspin works with BRCA1 to both positively and negatively regulate cell proliferation.	BRCA1 CLSPN	5.96e-05	2	269	2	15096610
Pubmed	Association analysis of ERBB2 amplicon genetic polymorphisms and STARD3 expression with risk of gastric cancer in the Chinese population.	ERBB2 STARD3	5.96e-05	2	269	2	24291029
Pubmed	Constitutive association of BRCA1 and c-Abl and its ATM-dependent disruption after irradiation.	ABL1 BRCA1	5.96e-05	2	269	2	12024016
Pubmed	Regulation of a late phase of T cell polarity and effector functions by Crtam.	CRTAM SCRIB	5.96e-05	2	269	2	18329370
Pubmed	Identification of Phf16 and Pnpla3 as new adipogenic factors regulated by phytochemicals.	JADE3 PNPLA3	5.96e-05	2	269	2	30272815
Pubmed	Combined Detection of HER2, Ki67, and GSTP1 Genes on the Diagnosis and Prognosis of Breast Cancer.	ERBB2 GSTP1	5.96e-05	2	269	2	30585764
Pubmed	NOD2/CARD15 genotype influences MDP-induced cytokine release and basal IL-12p40 levels in primary isolated peripheral blood monocytes.	NOD2 IL23R	5.96e-05	2	269	2	18383179
Pubmed	TNRC9 downregulates BRCA1 expression and promotes breast cancer aggressiveness.	BRCA1 TOX3	5.96e-05	2	269	2	23447579
Pubmed	SHARPIN Inhibits Esophageal Squamous Cell Carcinoma Progression by Modulating Hippo Signaling.	YAP1 SHARPIN	5.96e-05	2	269	2	31884247
Pubmed	RORα regulates hepatic lipolysis by inducing transcriptional expression of PNPLA3 in mice.	RORA PNPLA3	5.96e-05	2	269	2	33347955
Pubmed	Selective coupling of type 6 adenylyl cyclase with type 2 IP3 receptors mediates direct sensitization of IP3 receptors by cAMP.	ADCY6 ITPR2	5.96e-05	2	269	2	18936250
Pubmed	Vps18 deficiency inhibits dendritogenesis in Purkinje cells by blocking the lysosomal degradation of Lysyl Oxidase.	VPS18 LOX	5.96e-05	2	269	2	22699122
Pubmed	Store-dependent and -independent modes regulating Ca2+ release-activated Ca2+ channel activity of human Orai1 and Orai3.	ORAI1 ORAI3	5.96e-05	2	269	2	18420579
Pubmed	IL23R Arg381Gln is associated with childhood onset inflammatory bowel disease in Scotland.	NOD2 IL23R	5.96e-05	2	269	2	17337463
Pubmed	IL23R variation determines susceptibility but not disease phenotype in inflammatory bowel disease.	NOD2 IL23R	5.96e-05	2	269	2	17484863
Pubmed	The RhoA regulators Myo9b and GEF-H1 are targets of cyclic nucleotide-dependent kinases in platelets.	MYO9B ARHGEF2	5.96e-05	2	269	2	32692911
Pubmed	Association of NOD2 and IL23R with inflammatory bowel disease in Puerto Rico.	NOD2 IL23R	5.96e-05	2	269	2	25259511
Pubmed	Testing for ROS1, ALK, MET, and HER2 rearrangements and amplifications in a large series of biliary tract adenocarcinomas.	ERBB2 ROS1	5.96e-05	2	269	2	32447492
Pubmed	BRCA1 haploinsufficiency cell-autonomously activates RANKL expression and generates denosumab-responsive breast cancer-initiating cells.	BRCA1 TNFSF11	5.96e-05	2	269	2	28388533
Pubmed	A synthetic lethal screen identifies ATR-inhibition as a novel therapeutic approach for POLD1-deficient cancers.	ATR POLD1	5.96e-05	2	269	2	26755646
Pubmed	Both Orai1 and Orai3 are essential components of the arachidonate-regulated Ca2+-selective (ARC) channels.	ORAI1 ORAI3	5.96e-05	2	269	2	17991693
Pubmed	Facilitation of Orai3 targeting and store-operated function by Orai1.	ORAI1 ORAI3	5.96e-05	2	269	2	25791427
Pubmed	Double knockout of carbonic anhydrase II (CAII) and Na(+)-Cl(-) cotransporter (NCC) causes salt wasting and volume depletion.	CA2 SLC12A3	5.96e-05	2	269	2	24429824
Pubmed	FANCM regulates repair pathway choice at stalled replication forks.	BRCA1 FANCM	5.96e-05	2	269	2	33882298
Pubmed	Electrochemically driven drug metabolism via a CYP1A2-UGT1A10 bienzyme confined in a graphene nano-cage.	CYP1A2 UGT1A10	5.96e-05	2	269	2	25264962
Pubmed	The presence of fistulas and NOD2 homozygosity strongly predict intestinal stenosis in Crohn's disease independent of the IL23R genotype.	NOD2 IL23R	5.96e-05	2	269	2	20428899
Pubmed	Modeling ductal carcinoma in situ: a HER2-Notch3 collaboration enables luminal filling.	ERBB2 NOTCH3	5.96e-05	2	269	2	21743488
Pubmed	Polo-like kinase 1 mediates BRCA1 phosphorylation and recruitment at DNA double-strand breaks.	BRCA1 PLK1	5.96e-05	2	269	2	26745677
Pubmed	Targeting ABL-IRE1α Signaling Spares ER-Stressed Pancreatic β Cells to Reverse Autoimmune Diabetes.	ABL1 ERN1	5.96e-05	2	269	2	28380378
Pubmed	Repression of mRNA for the PLK cell cycle gene after DNA damage requires BRCA1.	BRCA1 PLK1	5.96e-05	2	269	2	14654792
Pubmed	Common variants in NOD2 and IL23R are not associated with inflammatory bowel disease in Indians.	NOD2 IL23R	5.96e-05	2	269	2	21155887
Pubmed	Polymorphism of interleukin-23 receptor gene but not of NOD2/CARD15 is associated with graft-versus-host disease after hematopoietic stem cell transplantation in children.	NOD2 IL23R	5.96e-05	2	269	2	19896081
Pubmed	Communication between N terminus and loop2 tunes Orai activation.	ORAI1 ORAI3	5.96e-05	2	269	2	29237733
Pubmed	Combined use of lysyl oxidase, carcino-embryonic antigen, and carbohydrate antigens improves the sensitivity of biomarkers in predicting lymph node metastasis and peritoneal metastasis in gastric cancer.	CEACAM5 LOX	5.96e-05	2	269	2	25060181
Pubmed	Dysferlin regulates cell membrane repair by facilitating injury-triggered acid sphingomyelinase secretion.	DYSF SMPD1	5.96e-05	2	269	2	24967968
Pubmed	ATR enforces the topoisomerase II-dependent G2 checkpoint through inhibition of Plk1 kinase.	ATR PLK1	5.96e-05	2	269	2	12147700
Pubmed	The role of PLK1-phosphorylated SVIL in myosin II activation and cytokinetic furrowing.	SVIL PLK1	5.96e-05	2	269	2	23750008
Pubmed	ATR-dependent phosphorylation of FANCM at serine 1045 is essential for FANCM functions.	ATR FANCM	5.96e-05	2	269	2	23698467
Pubmed	A genome-wide association study identifies IL23R as an inflammatory bowel disease gene.	NOD2 IL23R	5.96e-05	2	269	2	17068223
Pubmed	No evidence of association between common autoimmunity STAT4 and IL23R risk polymorphisms and non-anterior uveitis.	STAT4 IL23R	5.96e-05	2	269	2	24312163
Pubmed	Study on the effect of IRE1a on cell growth and apoptosis via modulation PLK1 in ER stress response.	ERN1 PLK1	5.96e-05	2	269	2	22314839
Pubmed	Hdac9 inhibits medial artery calcification through down-regulation of Osterix.	HDAC9 SP7	5.96e-05	2	269	2	32702412
Pubmed	Linking genetic susceptibility to Crohn's disease with Th17 cell function: IL-22 serum levels are increased in Crohn's disease and correlate with disease activity and IL23R genotype status.	NOD2 IL23R	5.96e-05	2	269	2	18022867
Pubmed	Encephalomyocarditis virus 3C protease attenuates type I interferon production through disrupting the TANK-TBK1-IKKε-IRF3 complex.	TANK TBK1	5.96e-05	2	269	2	28487378
Pubmed	A K(ATP) channel deficiency affects resting tension, not contractile force, during fatigue in skeletal muscle.	MAP1B KCNJ11	5.96e-05	2	269	2	11029282
Pubmed	Cocoa: a new mouse model for platelet storage pool deficiency.	CA2 HPS3	5.96e-05	2	269	2	3408670
Pubmed	Insufficient evidence for association of NOD2/CARD15 or other inflammatory bowel disease-associated markers on GVHD incidence or other adverse outcomes in T-replete, unrelated donor transplantation.	NOD2 IL23R	5.96e-05	2	269	2	20177049
Pubmed	Isolation of scFv antibody fragments against HER2 and CEA tumor antigens from combinatorial antibody libraries derived from cancer patients.	ERBB2 CEACAM5	5.96e-05	2	269	2	23845693
Pubmed	A novel native store-operated calcium channel encoded by Orai3: selective requirement of Orai3 versus Orai1 in estrogen receptor-positive versus estrogen receptor-negative breast cancer cells.	ORAI1 ORAI3	5.96e-05	2	269	2	20395295
Pubmed	PATJ and MPDZ are required for trophectoderm lineage specification in early mouse embryos.	MPDZ PATJ	5.96e-05	2	269	2	37318097
Pubmed	NOTCH3 signaling pathway plays crucial roles in the proliferation of ErbB2-negative human breast cancer cells.	ERBB2 NOTCH3	5.96e-05	2	269	2	18339869
Pubmed	A Significant Difference in Core PDZ Interactivity of SARS-CoV, SARS-CoV2 and MERS-CoV Protein E Peptide PDZ Motifs In Vitro.	MPDZ PATJ	5.96e-05	2	269	2	36932261
Interaction	PCDHB10 interactions	PCDHB10 PCDHB3 PCDHB16 MTNR1B	9.19e-07	7	260	4	int:PCDHB10
Cytoband	5q31	PCDHGC4 PCDHGA4 PCDHB15 PCDHB14 PCDHB13 PCDHB12 PCDHB11 PCDHB10 PCDHB9 PCDHB8 PCDHB7 PCDHB3 PCDHB16	2.16e-13	115	270	13	5q31
Cytoband	Ensembl 112 genes in cytogenetic band chr5q31	SEC24A GDF9 FCHSD1 PSD2 TRPC7 PCDHGC4 PCDHGA4 PCDHB15 PCDHB14 PCDHB13 PCDHB12 PCDHB11 PCDHB10 PCDHB9 PCDHB8 PCDHB7 PCDHB3 PCDHB16	2.93e-13	298	270	18	chr5q31
Cytoband	15q14-q15	RYR3 VPS18	3.41e-04	5	270	2	15q14-q15
Cytoband	1q21.1	NBPF14 NBPF8 NBPF9 NBPF10	4.99e-04	62	270	4	1q21.1
GeneFamily	Clustered protocadherins	PCDHGC4 PCDHGA4 PCDHB15 PCDHB14 PCDHB13 PCDHB12 PCDHB11 PCDHB10 PCDHB9 PCDHB8 PCDHB7 PCDHB3 PCDHB16	1.19e-13	64	192	13	20
GeneFamily	Neuroblastoma breakpoint family	NBPF26 NBPF19 NBPF14 NBPF8 NBPF20 NBPF15 NBPF9 NBPF10	5.98e-11	23	192	8	662
GeneFamily	ORAI calcium release-activated calcium modulators	ORAI1 ORAI3	3.34e-04	3	192	2	668
GeneFamily	Dyneins, axonemal	DNAH8 DNAH10 DNAH1	7.18e-04	17	192	3	536
GeneFamily	Cadherin related	CDHR2 FAT1 FAT4	7.18e-04	17	192	3	24
GeneFamily	Ferlin family	DYSF FER1L6	1.64e-03	6	192	2	828
Coexpression	MIKKELSEN_ES_HCP_WITH_H3K27ME3	SLC15A3 PCDHB15 PCDHB14 PCDHB12 PCDHB11 PCDHB7 PCDHB16	2.15e-07	42	268	7	MM1275
Coexpression	MIKKELSEN_ES_HCP_WITH_H3K27ME3	SLC15A3 PCDHB15 PCDHB14 PCDHB12 PCDHB7 PCDHB16	3.60e-06	41	268	6	M2000
Coexpression	FIGUEROA_AML_METHYLATION_CLUSTER_3_UP	CUL9 MOS TNFAIP8L2 PCDHB14 PCDHB11 PCDHB10 PCDHB9 PCDHB8 PCDHB16 ZFHX2	1.07e-05	170	268	10	M2168
ToppCell	NS-moderate-d_16-33-Epithelial-Secretory\|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	CFH ERBB2 CEACAM5 STEAP2 FER1L6 FAT1 PTPRZ1 CAPN5 LGALS3BP PLA2R1 LOX	3.19e-08	196	268	11	70384c1da9baed843f414cfd1403ddd586a2db07
ToppCell	Control-Myeloid-ncMonocyte\|World / Disease state, Lineage and Cell class	ERN1 MYO9B NBPF26 EPB41L3 NBPF19 NBPF14 AMPH HPS3 ZNF710 SIPA1L1	3.14e-07	195	268	10	b4444b67a709e82b8e2ee510924c3152cb88b051
ToppCell	10x_3'_v2v3-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia_independent-F\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	HDAC9 MAP1B RYR3 LENG8 ADAMTS1 PCDHB16 LGALS3BP CEMIP LOX PATJ	3.29e-07	196	268	10	b8b9801181d7604871b48aebacb295d0a57a5eaf
ToppCell	LPS-IL1RA-Unknown-Endothelial-Monocytes-Macrophages\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DLGAP2 SLC39A11 PBDC1 TRNAU1AP PRR14L ADAMTS1 POLD1 MRPS16 SLC38A7	6.64e-07	163	268	9	6b11a3ada8725670d0489f404c8c2175ad3904e9
ToppCell	CV-Mild-3\|Mild / Virus stimulation, Condition and Cluster	CFH ERBB2 GATB DYSF LRFN4 MINAR1 KMT5B SPDYE3 CLSPN	7.74e-07	166	268	9	5599f90fc0e15a3670b03187085eba91228390a2
ToppCell	5'-Adult-LargeIntestine-Hematopoietic-T_cells-Th17\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	JAML STAT4 ZNF469 TNFAIP8L2 RAD9B GPATCH2L SPDYE3 GAB3 RORA	8.55e-07	168	268	9	97bf074b91c9ae0064edc31fa4a2658ffdcfefa3
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	HDAC9 EPB41L3 JAML NLRC4 STAT4 CD163L1 LILRB5 TNFSF11 GAB3	8.55e-07	168	268	9	61a5435b27b01ff1a509ea463a6af220c5d2c9b3
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	HDAC9 EPB41L3 JAML NLRC4 STAT4 CD163L1 LILRB5 TNFSF11 GAB3	8.55e-07	168	268	9	26fce414439ccd204e3acb41f2b4f75072df5a26
ToppCell	ASK452-Immune-B_cell\|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq	B3GNT4 LRRC37A3 LRRC37A2 ITPR2 FARP2 RAD9B FANCM PCDHB16 ZNF750	1.15e-06	174	268	9	69723f5666abc3af5f0431901a60246c9915ef81
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L4_RORB_CACNG5\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	HDAC9 RYR3 ITPR2 NBPF19 NBPF14 USP53 CEMIP NBPF10 RORA	1.82e-06	184	268	9	658f2e522055e88c92bc482a845c40f8f5f1a8e3
ToppCell	Fetal_29-31_weeks-Immune-interstitial_macrophage_(C1Q_positive)-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	HDAC9 NPAS3 ITPR2 IER3 CD163L1 LILRB5 CD36 GAB3 SLC38A7	2.08e-06	187	268	9	39b99f46b723f7f3c44880d7fe8642cbad558b8a
ToppCell	10x5'-lymph-node_spleen-Lymphocytic_Invariant-Inducer-like\|lymph-node_spleen / Manually curated celltypes from each tissue	CFH ERN1 JAML STAT4 IER3 IL23R CA2 TNFSF11 RORA	2.37e-06	190	268	9	0c7eb8f4f2926af01bf44d5c9f239be7b81c67fe
ToppCell	ILEUM-inflamed-(1)_T_cell-(1)_Th17_Trm\|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	ERN1 JAML STAT4 NFKBIL1 IL23R CA2 TANK CPD RORA	2.58e-06	192	268	9	12f7ea575da5d650c740e6060f5dab0478e563dd
ToppCell	10x_5'_v1-Non-neoplastic-Lymphoid-NK\|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	STAT4 NBPF19 LRRC37A BRCA1 ADAMTS1 LPIN3 PTCH2 LRP5 CORO6	2.58e-06	192	268	9	930319cbd82b9e54864147ffcdc8bd0ea7b937be
ToppCell	10x_5'_v1-Non-neoplastic-Lymphoid-NK-NK\|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	STAT4 NBPF19 LRRC37A BRCA1 ADAMTS1 LPIN3 PTCH2 LRP5 CORO6	2.58e-06	192	268	9	c7bcebcb88a25b2c97d798120efa9d5958e7f798
ToppCell	10x5'v1-week_17-19-Mesenchymal_osteo-stroma-early_osteoblast\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	CFH MPDZ FAT1 GLIS2 NOTCH3 PCDHB9 LGALS3BP PLA2R1 SP7	2.70e-06	193	268	9	5e46a9f65e85aca78f825fdef88a95b97eec8743
ToppCell	Fetal_29-31_weeks-Immune-alveolar_macrophage_(MARCO_positive)-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	HDAC9 SLC15A3 ITPR2 IER3 CD163L1 C9 LILRB5 NR4A3 CD36	2.70e-06	193	268	9	2d0dd2671ff27b922eb316f1ed0140353536ef30
ToppCell	ILEUM-inflamed-(6)_ILC\|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	STAT4 SVIL NFKBIL1 IL23R CA2 CLIC3 GSTP1 TNFSF11 MCTP2	2.81e-06	194	268	9	4d51d49366c34ff1241770b4acc0167a43b3155a
ToppCell	NS-critical-LOC-Epithelial-Secretory\|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	CFH ERBB2 CEACAM5 STEAP2 FER1L6 CAPN5 ZNF750 LOX LRP5	2.93e-06	195	268	9	b0d782eeee30c797b4da9b3be29b864983fd9e71
ToppCell	Control-Lymphoid-CD4_T_cells\|Lymphoid / Condition, Lineage and Cell class	CFH ZNF219 ERN1 CFAP54 IER3 IL23R CA2 NBPF15 RORA	2.93e-06	195	268	9	8679a122fe796b1eddef82460e985b3fd3b3a2a5
ToppCell	distal-1-Hematologic-EREG+_Dendritic\|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	LRRC37A2 EPB41L3 ZNF469 IER3 CD163L1 NR4A3 KCNH3 SLC12A3 SEZ6L	3.46e-06	199	268	9	15249f2f48b1e99d9d062835fd4c705a159e4abb
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	C8orf89 GDF9 PIK3C2G SH3RF1 SAMD5 MYOM3 ADAMTSL3 SLC12A3	3.99e-06	152	268	8	eee86b508b8f140ea44e21d8c04c409a7b689e39
ToppCell	facs-Aorta-Heart-18m-Mesenchymal-fibrocyte\|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC15A3 JAML CD163L1 IL23R PSD2 PCDHB13 TNFSF11 SIPA1L1	4.84e-06	156	268	8	5b56217336771baf57d791efcb4e206c6aea83b1
ToppCell	facs-Marrow-KLS-3m-Lymphocytic-BM_CD8_+_CD4_T_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ERBB2 ZNF219 CDHR2 SIMC1 DNAH8 ABHD2 TNFSF11 RORA	5.57e-06	159	268	8	e967b557fe6ae4879d36f62c0297cbf6a2ad1ce9
ToppCell	facs-Marrow-KLS-3m-Lymphocytic-mature_alpha-beta_T_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ERBB2 ZNF219 CDHR2 SIMC1 DNAH8 ABHD2 TNFSF11 RORA	5.57e-06	159	268	8	9db971130509c62d439e0cab16588a4d994d7aa0
ToppCell	Mild-MAIT\|World / Disease group and Cell class	HDAC9 ERN1 JAML NYNRIN IL23R CA2 RORA PNPLA3	6.99e-06	164	268	8	21dc02997dfae73cf70ce291661928526605dba1
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Macrophage_Dendritic-Classical_Dendritic_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	HDAC9 SNX3 DYSF PTPRZ1 IL23R RAD9B ZNF710 PLEKHM3	7.64e-06	166	268	8	63dc58864268b4e7779e4c45155022556fc634f9
ToppCell	tumor_Lymph_Node_/_Brain-Myeloid_cells-Pleural_Mac\|Myeloid_cells / Location, Cell class and cell subclass	ERBB2 JADE3 JMJD4 RNF217 GTF3C3 TRNAU1AP PRR14L RANBP6	8.35e-06	168	268	8	8697b40b2ec2cce68ef3beb4792eb3eff29be053
ToppCell	E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_prolif\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	GDF9 RYR3 CFAP54 SH3RF1 FAM131A PLA2R1 LOX ANKS3	8.72e-06	169	268	8	16c52a0f6d96ecc1832922fce9b39691849f0d73
ToppCell	3'-Child04-06-SmallIntestine-Hematopoietic-T_cells-MAIT_cell\|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	JAML NLRC4 STAT4 LSM11 IL23R KCNH3 SPDYE3 RORA	9.10e-06	170	268	8	059f7ae615342ea19f43b0a405cd7272251a78a9
ToppCell	metastatic_Lymph_Node-Myeloid_cells-Microglia/Mac\|metastatic_Lymph_Node / Location, Cell class and cell subclass	ZNF862 SLC15A3 NOD2 POLD1 NR4A3 DNAH1 NBPF10 SLC38A7	9.91e-06	172	268	8	f673a2e697b46e7cfa4186cb3fb2b98e3c83703e
ToppCell	5'-Adult-LargeIntestine-Endothelial-lymphatic_endothelial-LEC3_(ADGRG3+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	DLGAP2 MPDZ DYSF ROBO4 PCDHB7 CDH22 LOX SLC41A1	1.03e-05	173	268	8	7dc988fc0ba29990567bf1bcdeb3faeeee507eb1
ToppCell	metastatic_Lymph_Node-Endothelial_cells-Lymphatic_ECs\|metastatic_Lymph_Node / Location, Cell class and cell subclass	DLGAP2 MPDZ LINC01558 ROBO4 PCDHB11 PCDHB7 CEMIP CDH13	1.08e-05	174	268	8	d551bc29afef071adf4c9bb80345352ec33441d8
ToppCell	3'-Child09-12-SmallIntestine-Hematopoietic-T_cells-MAIT_cell\|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ERN1 AMACR JAML STAT4 NBPF19 NBPF20 CRTAM RORA	1.27e-05	178	268	8	0290868dc990878eac5c182fe64968333bc52450
ToppCell	5'-GW_trimst-2-LargeIntestine-Epithelial-Tuft-related\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CEACAM5 CDHR2 NBPF26 HTR3C HEPACAM2 STEAP2 NBPF19 SYCN	1.38e-05	180	268	8	8ba9bba0c9fecf184a4332ba4585fb2439f68cd3
ToppCell	3'-Child09-12-SmallIntestine-Epithelial-Tuft-related-BEST4+_epithelial\|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CEACAM5 NBPF26 HEPACAM2 STEAP2 NBPF19 CA2 NBPF9 NBPF10	1.38e-05	180	268	8	b234668bf181522807470e396792e1b54890b719
ToppCell	mild_COVID-19-NK_CD56bright\|World / disease group, cell group and cell class (v2)	STAT4 IER3 DDIT4 NR4A3 LPIN3 TNFSF11 CRTAM MCTP2	1.55e-05	183	268	8	9a4899afac0f91203209392c5f67b3d0aa356b86
ToppCell	Control-Epithelial_cells-Airway_mucous\|Control / group, cell type (main and fine annotations)	CEACAM5 CDHR2 FER1L6 TOX3 CAPN5 CEMIP PLA2R1 GDA	1.55e-05	183	268	8	15d24a4fb1ffe6cbafbd54fcd7dde9ddcfbe03b2
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CSMD3 RYR3 FAT1 PIK3C2G FAT4 DNAH10 DNAH1 ROS1	1.62e-05	184	268	8	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CSMD3 RYR3 FAT1 PIK3C2G FAT4 DNAH10 DNAH1 ROS1	1.62e-05	184	268	8	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CSMD3 RYR3 FAT1 PIK3C2G FAT4 DNAH10 DNAH1 ROS1	1.62e-05	184	268	8	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	wk_20-22-Hematologic_Lymphocytic-T_&_ILC-ILC3\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	ERN1 JAML STAT4 IL23R CA2 DDIT4 CRTAM RORA	1.75e-05	186	268	8	ac1d2a94674bd15885e70502abad3a2ff3c21d73
ToppCell	ILEUM-inflamed-(1)_T_cell-(1)_Cytotoxic_CD8_Trm\|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	STAT4 IER3 CA2 CLIC3 NR4A3 CRTAM RORA ARHGEF2	1.89e-05	188	268	8	c80956649b10b7dd7540394a00fc2a0619b27e80
ToppCell	(6)_ILC\|World / Spleen cell shreds - cell class (v1) and cell subclass (v1)	CFH JAML NYNRIN SVIL NFKBIL1 IL23R DDIT4 TNFSF11	1.89e-05	188	268	8	de7cb273899d0e0748c85f45c6b5e7f0642ab057
ToppCell	Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel\|Children_(3_yrs) / Lineage, Cell type, age group and donor	DLGAP2 MAP1B NPAS3 DYSF LINC01558 ROBO4 CDH22 CD36	1.89e-05	188	268	8	c2805232618a7b6f844d34e37ad458a9923dbfe1
ToppCell	(6)_ILC\|World / Spleen cell shreds - cell class (v1) and cell subclass (v1)	CFH JAML NYNRIN SVIL NFKBIL1 IL23R DDIT4 TNFSF11	1.89e-05	188	268	8	f4734d5b703678670ece204a0519cf015e180a6e
ToppCell	COPD-Myeloid-cMonocyte\|COPD / Disease state, Lineage and Cell class	NBPF26 EPB41L3 DYSF NBPF19 NBPF14 SIPA1L1 NBPF10 MCTP2	1.96e-05	189	268	8	d29f3a0bd23e6eb46389e6eb7ef21851c7b57545
ToppCell	LV-14._Fibroblast_III\|World / Chamber and Cluster_Paper	ABL1 EPB41L3 RNF217 FAT1 RANBP2 ADAMTS1 NR4A3 RORA	1.96e-05	189	268	8	3922135d1f6fc768d71ba3b465585fead6ea68a8
ToppCell	10x5'-lymph-node_spleen-Lymphocytic_Invariant-Inducer-like-MAIT\|lymph-node_spleen / Manually curated celltypes from each tissue	CFH ERN1 JAML STAT4 IER3 IL23R CA2 RORA	1.96e-05	189	268	8	afe3a4fe7c10eeeb7064129778d940269c9acbef
ToppCell	Severe-MAIT\|World / Disease group and Cell class	CFH HDAC9 ERN1 JAML IL23R CA2 DDIT4 RORA	2.04e-05	190	268	8	7a92e0d6a021be23125495927b8571e25c83204a
ToppCell	3'-GW_trimst-1-SmallIntestine-Hematopoietic-T_cells-LTi-like_NCR-_ILC3\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	JAML STAT4 IL23R CLIC3 EYS TNFSF11 CRTAM RORA	2.04e-05	190	268	8	af39d2a46d9502cec69a69b7e8ffef78fc8311c3
ToppCell	Children_(3_yrs)-Immune-interstitial_macrophage_(C1Q_positive)-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	HDAC9 NPAS3 EPB41L3 IER3 CD163L1 C9 LILRB5 SIPA1L1	2.04e-05	190	268	8	2d54fca50593fbd11fe13fc2bfaf937a05db776d
ToppCell	primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Igfbp6_Pltp\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	HDAC9 NPAS3 MPDZ FAT1 PIK3C2G SVIL FAT4	2.15e-05	139	268	7	9e9f29f92dbe65b26cc78b3a1c00778c6a701f5b
ToppCell	Lymphoid-T_cells_(Cd8+_T_cell)\|World / shred on cell class and cell subclass (v4)	JAML STAT4 CD163L1 IL23R PSD2 TNFSF11 CRTAM	2.15e-05	139	268	7	c85f50fb536f4df6fa4dbdebe48e1ecea1df1121
ToppCell	MS-NK-\|MS / Condition, Cell_class and T cell subcluster	DDIT4 FAT4 ADAMTS1 CLIC3 GSTP1 TNFSF11 CRTAM MCTP2	2.20e-05	192	268	8	f97f5f8226f5c65ca93072ef35d753231bee2490
ToppCell	MS-NK\|MS / Condition, Cell_class and T cell subcluster	DDIT4 FAT4 ADAMTS1 CLIC3 GSTP1 TNFSF11 CRTAM MCTP2	2.20e-05	192	268	8	f44f5dd30db169fdd16c9d706d17ad44907a17af
ToppCell	nucseq\|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	MYO9B SLC39A11 EPB41L3 NBPF19 CD163L1 C9 NBPF14 SIPA1L1	2.28e-05	193	268	8	779276e775cb2492e8dd36436295a536084a6415
ToppCell	5'-Adult-SmallIntestine-Endothelial-lymphatic_endothelial-LEC3_(ADGRG3+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	DLGAP2 ITGA2B DYSF LINC01558 MAP4K2 ROBO4 LOX CD36	2.28e-05	193	268	8	bd0027fa97de41ae22ff64a61c8e217496f122ca
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	STEAP2 RNF217 USP53 ADAMTS1 NR4A3 ADAMTSL3 CORO6 RORA	2.28e-05	193	268	8	261cafc167c86ab277be4ea7f08b0173e2dde26e
ToppCell	BAL-Severe-Lymphocyte-T/NK-CD8+_T-MAIT\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	ERN1 JAML STAT4 IL23R CA2 DDIT4 CLIC3 RORA	2.45e-05	195	268	8	caa3669739974b63470f7e557df96e8d3844dd84
ToppCell	5'-GW_trimst-2-SmallIntestine-Hematopoietic-T_cells-LTi-like_NCR+_ILC3\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ERN1 JAML STAT4 IL23R CA2 EYS TNFSF11 RORA	2.45e-05	195	268	8	69201b1172bcf0999c726516e4d30863afceab0b
ToppCell	BAL-Severe-Lymphocyte-T/NK-CD8+_T-MAIT-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	ERN1 JAML STAT4 IL23R CA2 DDIT4 CLIC3 RORA	2.45e-05	195	268	8	bc5728e9df0b15adec50a7c840ce9f2775135087
ToppCell	Control-Myeloid-ncMonocyte\|Control / Disease state, Lineage and Cell class	ERN1 MYO9B NBPF26 EPB41L3 NBPF19 NBPF14 HPS3 SIPA1L1	2.45e-05	195	268	8	fcb05948e7480dc53f06f3fc9b9c3fc129874edd
ToppCell	5'-Adult-SmallIntestine-Epithelial-Tuft-related-BEST4+_epithelial\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CDHR2 NBPF26 HEPACAM2 STEAP2 ITPR2 NBPF19 GDA NBPF10	2.45e-05	195	268	8	e87b11e3242fdbed2e7f383e6876ec375af32bd4
ToppCell	TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-4\|TCGA-Prostate / Sample_Type by Project: Shred V9	CFH CAND2 ZNF469 NYNRIN GLIS2 LIPE ELF4 ARHGEF2	2.45e-05	195	268	8	5562665dd3beb70e2358aa32611a337bef5731c1
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW09-Macroglial-Astrocyte\|GW09 / Sample Type, Dataset, Time_group, and Cell type.	ZNF862 NOTCH3 FCHSD1 PCDHB13 GDA ORAI3 SLC41A1	2.47e-05	142	268	7	85e573616e54d41391b4ad8c3d38e4ca92112673
ToppCell	ILEUM-non-inflamed-(3)_Resident_macrophages\|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	EPB41L3 JAML IER3 CD163L1 NFKBIL1 LILRB5 TNFAIP8L2 CD36	2.64e-05	197	268	8	3af24354b6a93c7d105b9fa6549cf215107b9203
ToppCell	(5)_Fibroblasts-(5)_Fibroblast-E\|(5)_Fibroblasts / Lung cell shreds - cell class (v4) and cell subclass (v4)	CFH SVIL ART5 DDIT4 CLIC3 LGALS3BP ORAI3 RORA	2.64e-05	197	268	8	9b1c1d72c5a8c90d71ae31e4c198d2276872eaa0
ToppCell	ILEUM-non-inflamed-(6)_ILC\|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	SVIL NFKBIL1 IL23R CA2 CLIC3 GSTP1 TNFSF11 MCTP2	2.64e-05	197	268	8	76a233eb9611d24b9bb9f4359c26606332a3c29e
ToppCell	Sepsis-URO-Lymphocyte-T/NK-MAIT\|URO / Disease, condition lineage and cell class	CFH CSMD3 LRRC37A IL23R EYS ASB16 RORA SLC41A1	2.74e-05	198	268	8	75db638278d4be2b0f406cd8871058a8352c5a86
ToppCell	Parenchymal-NucSeq-Endothelial-Endothelia_lymphatic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	DLGAP2 NPAS3 DYSF LINC01558 MAP4K2 ROBO4 CDH22 CD36	2.74e-05	198	268	8	9ab0db78394e730f6866b2db80047149024ad5f6
ToppCell	Tracheal-10x5prime-Endothelial-Endothelia_lymphatic-Endothelia_Lymphatic\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	DLGAP2 HTR3C DYSF LINC01558 CD163L1 MAP4K2 ROBO4 CD36	2.74e-05	198	268	8	306e28d31fd587409a12dcccc6b2abd7dc9c2e0a
ToppCell	(1)_T_cell-(13)_Th17\|(1)_T_cell / shred on Cell_type and subtype	ERN1 JAML STAT4 NFKBIL1 IL23R CA2 TANK RORA	2.74e-05	198	268	8	a3ac65295da7baed447786a302b01db1cc824db2
ToppCell	10x3'2.3-week_14-16-Mesenchymal_osteo-stroma-osteoblast_precursor\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	CFH MAP1B FAT1 YAP1 NOTCH3 DDIT4 LGALS3BP SP7	2.74e-05	198	268	8	9d61483b0decac2fe90045b3474843360b2c49b3
ToppCell	Tracheal-10x5prime-Endothelial-Endothelia_lymphatic\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	DLGAP2 HTR3C DYSF LINC01558 CD163L1 MAP4K2 ROBO4 CD36	2.74e-05	198	268	8	05429f18e1d74880c1835568c86177f661b3477a
ToppCell	10x5'v1-week_14-16-Mesenchymal_osteo-stroma-osteoblast_precursor\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	CFH MAP1B FAT1 YAP1 NOTCH3 LGALS3BP LOX SP7	2.74e-05	198	268	8	bc9c9f2c87282b5ef8514773e065d2a6b5dde338
ToppCell	Parenchymal-NucSeq-Endothelial-Endothelia_lymphatic-Endothelia_Lymphatic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	DLGAP2 NPAS3 DYSF LINC01558 MAP4K2 ROBO4 CDH22 CD36	2.74e-05	198	268	8	e47d0e2c6353315c85d7007742bb16b0f05795ed
ToppCell	ILEUM-inflamed-(6)_ILC-(6)_ILC3\|(6)_ILC / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	HDAC9 JAML SVIL NFKBIL1 IL23R CA2 TNFSF11 RORA	2.84e-05	199	268	8	02879df850b0c72b57d7b22cfc43f3407e182dcb
ToppCell	wk_15-18-Hematologic-Myeloid-SPP1+_Mac\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	MYO9B EPB41L3 SLC15A3 ITPR2 IER3 CD163L1 LILRB5 CD36	2.84e-05	199	268	8	c7fc2ac1601346aac71e7620a8a440fde8d92dbd
ToppCell	Brain_organoid-organoid_Paulsen_bioRxiv-1_mon-Proliferating-Cycling_Progenitors\|1_mon / Sample Type, Dataset, Time_group, and Cell type.	NPAS3 MPDZ FAT1 YAP1 TOX3 NOTCH3 FAT4 E2F5	2.84e-05	199	268	8	358c4b3037f59378db8916a2fbe9ed4830cf1449
ToppCell	wk_20-22-Hematologic-Myeloid-SPP1+_Mac\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	MYO9B EPB41L3 SLC15A3 ITPR2 IER3 CD163L1 LILRB5 CD36	2.84e-05	199	268	8	7c19f1b1f4369edd035ca9cdcf4e653771fc4648
ToppCell	control-Epithelial-Secretory\|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	CFH ERBB2 PTPRZ1 DDIT4 CPD LGALS3BP PLA2R1 CD36	2.84e-05	199	268	8	3d01f90ffd271ca00129192787e4921bdca7e01e
ToppCell	control-Epithelial-Secretory\|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	CFH ERBB2 STEAP2 PTPRZ1 CPD LGALS3BP PLA2R1 CD36	2.84e-05	199	268	8	262e5b8a52c8ddb0b47048c786e8bdb7158e1b9a
ToppCell	Neuronal-Excitatory-eC(RORB)-eC_1-CARM1P1--L3-4\|Neuronal / cells hierarchy compared to all cells using T-Statistic	NBPF26 NBPF19 PIK3C2G PTPRZ1 NBPF14 PLA2R1 NBPF10 ROS1	2.94e-05	200	268	8	47791c93d03ee17c1ce17e27f075be4fc6f2590e
ToppCell	10x5'v1-week_14-16-Mesenchymal_osteo-stroma-early_osteoblast\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	CFH MAP1B FAT1 PTPRZ1 NOTCH3 LGALS3BP LOX SP7	2.94e-05	200	268	8	16a7c398626b6e82b394eb3ef013bda3a788659d
ToppCell	LPS_anti-TNF-Hematopoietic_Myeloid-Dendritic_cells-pDC\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	HDAC9 ERN1 JAML TNFAIP8L2 POLD1 RBP3 NR4A3 EYS	2.94e-05	200	268	8	6a34e07e6d77fe3fdd9ff44c4b1e46a023f6d6a2
ToppCell	Neuronal-Excitatory-eC(RORB)-eC_1-CARM1P1\|Neuronal / cells hierarchy compared to all cells using T-Statistic	NBPF26 NBPF19 PIK3C2G PTPRZ1 NBPF14 PLA2R1 NBPF10 ROS1	2.94e-05	200	268	8	f75d95376a340d467c4392b872b2a2dbdd184556
ToppCell	10x5'v1-week_14-16-Mesenchymal_osteo\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	CFH MAP1B FAT1 PTPRZ1 NOTCH3 LGALS3BP LOX SP7	2.94e-05	200	268	8	780d47f8eff630020dfae32218de495a7e9dbad6
ToppCell	10x5'v1-week_14-16-Mesenchymal_osteo-stroma\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	CFH MAP1B FAT1 PTPRZ1 NOTCH3 LGALS3BP LOX SP7	2.94e-05	200	268	8	28dd127787a57276253548d1f030814b1af64481
ToppCell	distal-Hematologic-EREG+_Dendritic-1\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	EPB41L3 ZNF469 LRRC37A CD163L1 NR4A3 KCNH3 SLC12A3 SEZ6L	2.94e-05	200	268	8	7809c74a2e52768854b66a135522138281bc4449
ToppCell	Neuronal-Excitatory-eC(RORB)-eC_1-CARM1P1-\|Neuronal / cells hierarchy compared to all cells using T-Statistic	NBPF26 NBPF19 PIK3C2G PTPRZ1 NBPF14 PLA2R1 NBPF10 ROS1	2.94e-05	200	268	8	fae26560ba3b0b638b6bcf92f05330824b31d21b
ToppCell	COVID-19-kidney-Technical/muscle\|kidney / Disease (COVID-19 only), tissue and cell type	DLGAP2 CSMD3 TMEM132B DNAH8 EYS CLSPN CDH13	3.22e-05	148	268	7	0dbd87078f54ee1c2f8ec64e8bac9dfddb9c181e
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	NPAS3 IER3 PIK3C2G TRPC7 SAMD5 MRPS25 ROS1	3.66e-05	151	268	7	f4f7156b2c0cfc78fd1841e07c9915d97ced561f
ToppCell	VE-CD8-memory_CD4\|VE / Condition, Cell_class and T cell subcluster	CFH ERN1 RYR3 STAT4 CAMSAP3 GAB3 RORA	3.82e-05	152	268	7	9401b7770c1bdc87eba25e82922f5dd1c4fa37ee
ToppCell	PND03-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	JAML CD163L1 IL23R PSD2 TNFSF11 RORA CLSPN	4.15e-05	154	268	7	d0a1ff02a7e91f6923aa85b65094f78e357e377d
ToppCell	5'-Adult-Appendix-Epithelial-Tuft-related-BEST4+_epithelial\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CEACAM5 NPAS3 NBPF26 HEPACAM2 NBPF19 NBPF10 PTCH2	4.32e-05	155	268	7	5fabe24a784f0be46040ffc886eabd8d5ce78121
ToppCell	18-Airway-Epithelial-Bud_tip_progenitor\|Airway / Age, Tissue, Lineage and Cell class	PIK3C2G CA2 USP53 ADAMTS1 CLIC3 CD36 ROS1	5.08e-05	159	268	7	e715cadff8e7d5ebe4c2198dbdfd3ca41ecb8a6a
ToppCell	COVID-19-kidney-Technical/muscle_(Mes)\|kidney / Disease (COVID-19 only), tissue and cell type	DLGAP2 CSMD3 TMEM132B DNAH8 EYS CDH4 CDH13	5.08e-05	159	268	7	5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d
ToppCell	facs-Lung-Endomucin-24m-Lymphocytic-mature_NK_T_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CUL9 EPB41L3 RYR3 GLIS2 TRPC7 CEMIP ZFHX2	5.08e-05	159	268	7	4000ed0d3b7d488722bcd0042fa2ff4405aaab82
ToppCell	facs-Lung-Endomucin-24m-Lymphocytic-Natural_Killer_T_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CUL9 EPB41L3 RYR3 GLIS2 TRPC7 CEMIP ZFHX2	5.08e-05	159	268	7	7619d0d49738dd08daf01b42664691a5323aa793
Disease	obesity (implicated_via_orthology)	STAT4 ITPR2 NOTCH3 FAT4 DNAH10 LPIN3 GSTP1 CD36 ZFHX2 PNPLA3	1.48e-05	215	247	10	DOID:9970 (implicated_via_orthology)
Disease	Malignant neoplasm of breast	ERBB2 ABL1 ACO2 LRRC37A2 HEPACAM2 EPB41L3 DYSF STAT4 LRRC37A BRCA1 YAP1 TOX3 NOTCH3 TANK ADAMTS1 PCDHB15 FAM131A HELQ GSTP1 LIPE SIPA1L1 DHX32 CLSPN	4.00e-05	1074	247	23	C0006142
Disease	alcohol use disorder (implicated_via_orthology)	ERBB2 SREBF1 RYR3 MAP4K2 NOTCH3 PSD2 CLIC3 SMARCC1 SMARCC2	4.21e-05	195	247	9	DOID:1574 (implicated_via_orthology)
Disease	urinary bladder cancer (is_implicated_in)	ERBB2 AMACR BRCA1 PLK1 GSTP1 CDH13	4.34e-05	76	247	6	DOID:11054 (is_implicated_in)
Disease	Proliferative vitreoretinopathy	CAPN5 LRP5	6.98e-05	2	247	2	C0242852
Disease	Disease Exacerbation	ERBB2 DDB1 YAP1 CLN3 RANBP10 E2F5 GSTP1 NAXD	7.98e-05	165	247	8	C0235874
Disease	Glioma	ERBB2 ATR DMXL1 PLK1 GSTP1 ROS1	9.28e-05	87	247	6	C0017638
Disease	ovarian cancer (is_implicated_in)	ERBB2 NOD2 BRCA1 GSTP1 CDH13	1.06e-04	56	247	5	DOID:2394 (is_implicated_in)
Disease	tyrosine-protein kinase transmembrane receptor ROR2 measurement	CFH RORA	2.08e-04	3	247	2	EFO_0803209
Disease	neovascular inflammatory vitreoretinopathy (is_implicated_in)	CAPN5 LRP5	2.08e-04	3	247	2	DOID:9719 (is_implicated_in)
Disease	neurogenic locus notch homolog protein 2 measurement	CFH NBPF10	2.08e-04	3	247	2	EFO_0020599
Disease	glucose-6-phosphate isomerase measurement	CFH CD163L1	2.08e-04	3	247	2	EFO_0020407
Disease	Stomach Neoplasms	ERBB2 ATR DDB1 CLN3 CA2 RANBP10 FAT4 GSTP1 NAXD RORA	2.19e-04	297	247	10	C0038356
Disease	Malignant neoplasm of stomach	ERBB2 ATR DDB1 CLN3 CA2 RANBP10 FAT4 GSTP1 NAXD RORA	2.37e-04	300	247	10	C0024623
Disease	colorectal carcinoma (is_marker_for)	BRCA1 CA2 SEPHS2 SMARCC1	2.55e-04	37	247	4	DOID:0080199 (is_marker_for)
Disease	Malignant Glioma	ERBB2 DMXL1 PLK1 GSTP1 ROS1	3.07e-04	70	247	5	C0555198
Disease	mixed gliomas	ERBB2 DMXL1 PLK1 GSTP1 ROS1	3.07e-04	70	247	5	C0259783
Disease	Colorectal Carcinoma	CYP1A2 MAP1B AMACR ETFDH HTR3C CSMD3 FAT1 YAP1 DNAH8 VPS18 POLD1 RBP3 ADAMTSL3 HPS3 CDH22 RPAP1	3.10e-04	702	247	16	C0009402
Disease	childhood trauma measurement, alcohol consumption measurement	DLGAP2 DDIT4 PCDHGC4 PCDHGA4 PLA2R1	3.28e-04	71	247	5	EFO_0007878, EFO_0007979
Disease	Non-Small Cell Lung Carcinoma	ERBB2 NOTCH3 ADAMTS1 E2F5 GSTP1 ROS1 CDH13	3.58e-04	156	247	7	C0007131
Disease	Antibody Deficiency Syndrome	CFH C9 CD36	3.61e-04	17	247	3	C0003257
Disease	Liver carcinoma	CYP1A2 ACO2 SREBF1 STAT4 YAP1 C9 PLK1 LILRB5 NOTCH3 CA2 ADAMTS1 GSTP1 CDH13	3.80e-04	507	247	13	C2239176
Disease	glucose measurement	CAND2 ERN1 LRRC37A3 ETFDH STEAP2 LRRC37A PIK3C2G ZC3H4 KCNJ11 MAP4K2 MTNR1B	3.91e-04	380	247	11	EFO_0004468
Disease	hepatocellular carcinoma, non-alcoholic steatohepatitis	DYSF PNPLA3	4.14e-04	4	247	2	EFO_0000182, EFO_1001249
Disease	receptor tyrosine-protein kinase erbb-3 measurement	CFH SMARCC2	4.14e-04	4	247	2	EFO_0020701
Disease	esophagus squamous cell carcinoma (is_implicated_in)	EPB41L3 FAT1 BRCA1 GSTP1	5.45e-04	45	247	4	DOID:3748 (is_implicated_in)
Disease	type 2 diabetes mellitus (is_implicated_in)	SREBF1 PIK3C2G KCNJ11 GSTP1 CD36 MTNR1B PNPLA3	6.19e-04	171	247	7	DOID:9352 (is_implicated_in)
Disease	asthma	HDAC9 ERBB2 MYO9B ACO2 DYSF CSMD3 NOD2 NFKBIL1 GAL3ST3 STARD3 SAMD5 RANBP6 ADAMTSL3 TNFRSF8 SHARPIN RORA	6.44e-04	751	247	16	MONDO_0004979
Disease	Familial Exudative Vitreoretinopathy	RCBTB1 LRP5	6.86e-04	5	247	2	C0339539
Disease	kallikrein-7 measurement	CD163L1 LILRB5	6.86e-04	5	247	2	EFO_0008195
Disease	urate measurement, bone density	DLGAP2 NPAS3 ITPR2 LARP4B YAP1 GLIS2 DNAH8 FAM234B UGT1A10 DNAH1 EYS MRPS25 CDH4 CDH13	7.89e-04	619	247	14	EFO_0003923, EFO_0004531
Disease	Hereditary Diffuse Gastric Cancer	ERBB2 DDB1 CLN3 CA2 RANBP10 FAT4 GSTP1 NAXD RORA	8.66e-04	293	247	9	C1708349
Disease	Immunologic Deficiency Syndromes	CFH C9 CD36	9.07e-04	23	247	3	C0021051
Disease	smoking status measurement, triglyceride measurement	B3GNT4 DGCR8	1.02e-03	6	247	2	EFO_0004530, EFO_0006527
Disease	hydrocephalus (is_implicated_in)	MPDZ SMARCC1	1.02e-03	6	247	2	DOID:10908 (is_implicated_in)
Disease	interleukin-23 receptor measurement	CFH IL23R	1.02e-03	6	247	2	EFO_0801725
Disease	hemolytic-uremic syndrome (is_implicated_in)	CFH CD36	1.02e-03	6	247	2	DOID:12554 (is_implicated_in)
Disease	trans fatty acid measurement, trans/trans-18:2 fatty acid measurement	GATB RYR3 CDH13	1.03e-03	24	247	3	EFO_0006821, EFO_0006826
Disease	fasting blood glucose measurement, HOMA-B, fasting blood insulin measurement	ETFDH MAP4K2 MTNR1B	1.16e-03	25	247	3	EFO_0004465, EFO_0004466, EFO_0004469
Disease	L lactate dehydrogenase measurement	CFH CD163L1 LILRB5	1.31e-03	26	247	3	EFO_0004808
Disease	neurofilament light chain measurement	DLGAP2 DMXL1 ADAMTS1 SMCR8	1.34e-03	57	247	4	EFO_0009178
Disease	arteriosclerosis (implicated_via_orthology)	LIPE LOX	1.43e-03	7	247	2	DOID:2349 (implicated_via_orthology)
Disease	limb-girdle muscular dystrophy (implicated_via_orthology)	DYSF FER1L6	1.43e-03	7	247	2	DOID:11724 (implicated_via_orthology)
Disease	glutathione s-transferase p measurement	CFH GSTP1	1.43e-03	7	247	2	EFO_0020410
Disease	creatine kinase measurement	CAND2 CD163L1 LILRB5 ROS1	1.52e-03	59	247	4	EFO_0004534
Disease	Insulin Sensitivity	SREBF1 KCNJ11 NR4A3 CD36	1.62e-03	60	247	4	C0920563
Disease	Insulin Resistance	SREBF1 KCNJ11 NR4A3 CD36	1.62e-03	60	247	4	C0021655
Disease	Mammary Carcinoma, Human	ERBB2 ABL1 LRRC37A2 EPB41L3 LRRC37A BRCA1 YAP1 TOX3 NOTCH3 TANK ADAMTS1 GSTP1	1.69e-03	525	247	12	C4704874
Disease	Mammary Neoplasms, Human	ERBB2 ABL1 LRRC37A2 EPB41L3 LRRC37A BRCA1 YAP1 TOX3 NOTCH3 TANK ADAMTS1 GSTP1	1.69e-03	525	247	12	C1257931
Disease	breast cancer (is_implicated_in)	CYP1A2 NOD2 BRCA1 MCPH1 GSTP1 CDH13	1.70e-03	150	247	6	DOID:1612 (is_implicated_in)
Disease	Osteoporosis, Age-Related	CAP1 CA2 TNFSF11 LRP5	1.72e-03	61	247	4	C0001787
Disease	Post-Traumatic Osteoporosis	CAP1 CA2 TNFSF11 LRP5	1.72e-03	61	247	4	C0751406
Disease	Osteoporosis, Senile	CAP1 CA2 TNFSF11 LRP5	1.72e-03	61	247	4	C0029459
Disease	Mammary Neoplasms	ERBB2 ABL1 LRRC37A2 EPB41L3 LRRC37A BRCA1 YAP1 TOX3 NOTCH3 TANK ADAMTS1 GSTP1	1.74e-03	527	247	12	C1458155
Disease	Neoplasm of uncertain or unknown behavior of ovary	ERBB2 ATR BRCA1	1.80e-03	29	247	3	C0496920
Disease	arteriosclerosis (is_marker_for)	LIPE CD36 CDH13	1.80e-03	29	247	3	DOID:2349 (is_marker_for)
Disease	pneumococcal meningitis	PCDHB11 ROS1	1.89e-03	8	247	2	EFO_1001114
Disease	tyrosine-protein kinase receptor TYRO3 measurement	CFH RPAP1	1.89e-03	8	247	2	EFO_0020829
Disease	sialic acid-binding Ig-like lectin 6 measurement	CFH CEACAM18	1.89e-03	8	247	2	EFO_0008285
Disease	plasma clozapine measurement	CYP1A2 UGT1A10	1.89e-03	8	247	2	EFO_0600038
Disease	coloboma (implicated_via_orthology)	YAP1 PTCH2	1.89e-03	8	247	2	DOID:12270 (implicated_via_orthology)
Disease	Osteoporosis	CAP1 CA2 TNFSF11 LRP5	1.94e-03	63	247	4	C0029456
Disease	Ovarian Carcinoma	ERBB2 ATR BRCA1	1.99e-03	30	247	3	C0029925
Disease	asthma, cardiovascular disease	ERBB2 STARD3 RANBP6	1.99e-03	30	247	3	EFO_0000319, MONDO_0004979
Disease	carcinoma (implicated_via_orthology)	ERBB2 YAP1 FAT4 SCRIB	2.05e-03	64	247	4	DOID:305 (implicated_via_orthology)
Disease	Breast Carcinoma	ERBB2 ABL1 LRRC37A2 EPB41L3 LRRC37A BRCA1 YAP1 TOX3 NOTCH3 TANK ADAMTS1 GSTP1	2.07e-03	538	247	12	C0678222
Disease	osteoporosis (is_implicated_in)	GSTP1 TNFSF11 LRP5	2.19e-03	31	247	3	DOID:11476 (is_implicated_in)
Disease	intestinal cancer (implicated_via_orthology)	ERBB2 YAP1 NOTCH3	2.40e-03	32	247	3	DOID:10155 (implicated_via_orthology)
Disease	Large cell carcinoma of lung	ABL1 ATR ROS1	2.40e-03	32	247	3	C0345958
Disease	opportunistic bacterial infectious disease (implicated_via_orthology)	SMARCC1 SMARCC2	2.42e-03	9	247	2	DOID:0050340 (implicated_via_orthology)
Disease	Glioma	ERBB2 PTCH2	2.42e-03	9	247	2	cv:C0017638
Disease	Coffin-Siris syndrome (implicated_via_orthology)	SMARCC1 SMARCC2	2.42e-03	9	247	2	DOID:1925 (implicated_via_orthology)
Disease	kallikrein-11 measurement	CFH GAL3ST3	2.42e-03	9	247	2	EFO_0010573
Disease	protein-tyrosine kinase 6 measurement	CFH UGT1A10	2.42e-03	9	247	2	EFO_0020691
Disease	chronic central serous retinopathy	CFH RORA	2.42e-03	9	247	2	EFO_0009363
Disease	testis-specific chromodomain protein Y 1 measurement	CFH UGT1A10	2.42e-03	9	247	2	EFO_0802127
Disease	susceptibility to mononucleosis measurement	HDAC9 DLGAP2 DNAH8 FAT4	2.71e-03	69	247	4	EFO_0008403
Disease	Nonalcoholic Steatohepatitis	CYP1A2 SREBF1 GSTP1 PNPLA3	2.85e-03	70	247	4	C3241937
Disease	Non-alcoholic Fatty Liver Disease	CYP1A2 SREBF1 GSTP1 PNPLA3	2.85e-03	70	247	4	C0400966
Disease	Prescription Drug Abuse	CSMD3 DNAH8 PLA2R1 PATJ CDH13	2.87e-03	115	247	5	C4316881
Disease	Substance-Related Disorders	CSMD3 DNAH8 PLA2R1 PATJ CDH13	2.87e-03	115	247	5	C0236969
Disease	Organic Mental Disorders, Substance-Induced	CSMD3 DNAH8 PLA2R1 PATJ CDH13	2.87e-03	115	247	5	C0029231
Disease	Drug habituation	CSMD3 DNAH8 PLA2R1 PATJ CDH13	2.87e-03	115	247	5	C0013170
Disease	Drug abuse	CSMD3 DNAH8 PLA2R1 PATJ CDH13	2.87e-03	115	247	5	C0013146
Disease	Drug Use Disorders	CSMD3 DNAH8 PLA2R1 PATJ CDH13	2.87e-03	115	247	5	C0013222
Disease	Drug Dependence	CSMD3 DNAH8 PLA2R1 PATJ CDH13	2.87e-03	115	247	5	C1510472
Disease	Substance Dependence	CSMD3 DNAH8 PLA2R1 PATJ CDH13	2.87e-03	115	247	5	C0038580
Disease	Substance Use Disorders	CSMD3 DNAH8 PLA2R1 PATJ CDH13	2.87e-03	115	247	5	C0038586
Disease	Adenocarcinoma	ERBB2 ABL1 CA2 FAT4 SMARCC1	2.98e-03	116	247	5	C0001418
Disease	Carcinoma, Granular Cell	ERBB2 ABL1 CA2 FAT4 SMARCC1	2.98e-03	116	247	5	C0205644
Disease	Adenocarcinoma, Tubular	ERBB2 ABL1 CA2 FAT4 SMARCC1	2.98e-03	116	247	5	C0205645
Disease	Adenocarcinoma, Oxyphilic	ERBB2 ABL1 CA2 FAT4 SMARCC1	2.98e-03	116	247	5	C0205642
Disease	Carcinoma, Cribriform	ERBB2 ABL1 CA2 FAT4 SMARCC1	2.98e-03	116	247	5	C0205643
Disease	Adenocarcinoma, Basal Cell	ERBB2 ABL1 CA2 FAT4 SMARCC1	2.98e-03	116	247	5	C0205641
Disease	Substance abuse problem	CSMD3 DNAH8 PLA2R1 PATJ CDH13	2.98e-03	116	247	5	C0740858
Disease	celiac disease (is_implicated_in)	MYO9B IL23R	3.00e-03	10	247	2	DOID:10608 (is_implicated_in)
Disease	Behcet's disease (is_implicated_in)	STAT4 NOD2 IL23R	3.37e-03	36	247	3	DOID:13241 (is_implicated_in)
Disease	mortality	NLRC4 LINC01558 NYNRIN SVIL CEMIP CMTM7	3.46e-03	173	247	6	EFO_0004352
Disease	autosomal dominant nonsyndromic deafness (is_implicated_in)	MAP1B THOC1	3.65e-03	11	247	2	DOID:0050564 (is_implicated_in)
Disease	kidney cancer	MCPH1 RORA	3.65e-03	11	247	2	MONDO_0002367

Protein segments in the cluster

Peptide	Gene	Start	Entry
PLDDYVNTQGPSLFS	PLGLB1	21	Q02325
KQGLLPLTFADPADY	ACO2	701	Q99798
NEDLGPASPLDSTFY	ERBB2	991	P04626
GPDYVLLRSNPDDFN	CEACAM18	226	A8MTB9
PNIPEFAALDLLSSY	CFAP54	2741	Q96N23
PEEGLSYLAASEAPL	AMZ1	381	Q400G9
FLYIYDGPDSNSPLI	CSMD3	1641	Q7Z407
SPLKSVDFLDAYPGI	ACOX3	481	O15254
LNYDTFGLAVPSTLP	ALDH16A1	501	Q8IZ83
GPPATIFDNYDLLLG	ADCY6	856	O43306
AFLAPSATTYIGLNP	SMPD1	481	P17405
FAPGSQLPILLYDSD	CLIC3	56	O95833
PPDLYFQDSGLSRFL	ABHD2	41	P08910
ENPYAPLNLLADFAG	AMACR	141	Q9UHK6
SLPAGDALYLSFNPP	ARHGEF2	886	Q92974
SDSVILNVLYGPDAP	CEACAM5	226	P06731
LDANDPPIFTLNIYS	FAT4	3396	Q6V0I7
FSDPLTGAPSQYLER	C8orf89	116	P0DMQ9
PEVLFAALLDYGAQP	ASB16	336	Q96NS5
APYVQAFDSLLAGPV	CAP1	41	Q01518
LSLYLLDDEPDGPFS	BRWD3	1506	Q6RI45
ALSFYLPAESENRAP	HTR3C	266	Q8WXA8
YPDALQSPFGDLSLK	DLGAP2	326	Q9P1A6
LVLYDATSLPAGADP	GATB	346	O75879
DPQSTYGFTPLALAA	ASB14	211	A6NK59
LFEDPLFPATDDSLY	CAPN5	26	O15484
DNGDITSFPLSVYAP	CFH	1116	P08603
PFDPILASSGIDYDI	DCAF6	771	Q58WW2
YTALFLAIDSGNPPA	CDH13	551	P55290
LANVSDPYLSAVPEG	CD163L1	1011	Q9NR16
VSNRYFNPSGEPLEL	CCNQ	96	Q8N1B3
LPAEDPFNFYGASLL	DGCR8	61	Q8WYQ5
EDLELNPFDGLPYSS	DHX32	36	Q7L7V1
PRLLPDGAADGSFYL	CAMSAP3	471	Q9P1Y5
NDFPSHPLYLEGALT	CEMIP	1021	Q8WUJ3
YPFAGHDLAELPVSS	DMXL1	2506	Q9Y485
EPLFAGTDRNPYLLS	DLGAP4	21	Q9Y2H0
GTDRNPYLLSPTEAF	DLGAP4	26	Q9Y2H0
SAREASQELPPGFLY	AMPH	611	P49418
YPGPSLDAVAAFAAI	C17orf113	506	A0A1B0GUU1
EYIPLTPAAADVNGS	GMEB2	196	Q9UKD1
PPEDAIGLLDLATSY	RCBTB1	436	Q8NDN9
IAFTDLPANLYPTVG	RANBP10	191	Q6VN20
PPAAYSNSESLLGLL	RANBP2	1056	P49792
SDPGLTAPLYLFLGN	OR4N4C	51	A0A096LPK9
SSGNPLDFFPILRYL	CYP1A2	231	P05177
LLGEAYFIQPLPAAS	ADAMTS1	151	Q9UHI8
PDGSAPSAHVEFYLL	PIK3C2G	1356	O75747
VLYSPELLFPEGSDA	ITPR2	1631	Q14571
ECNPPNLALYLLGFE	NUP205	996	Q92621
EPTFALLGFTDYPKL	OR5D14	11	Q8NGL3
SDHEYPPGLLVAFSA	ORAI3	86	Q9BRQ5
AGLHDSLALYPEFAP	KCNH3	676	Q9ULD8
NPYTGATFLLAALPT	MAP4K2	606	Q12851
IYFDFPGKPLALSID	RAD9B	246	Q6WBX8
SYLDEAASAPAIPEG	CHMP5	181	Q9NZZ3
PSADPDDSGLTLYLV	PCDHGA4	711	Q9Y5G9
LGPATAFLQRPYFDS	FAT1	4221	Q14517
VLDANDNSPFVLYPL	PCDHB13	551	Q9Y5F0
LHLDFAPSPFGTLYD	FAM189A1	266	O60320
AGTLLTEFNAAYVPP	FAM166C	6	A6NJV1
LPSLDSENAALYFPQ	LPIN3	386	Q9BQK8
FNYPLLSSPGDQFEI	LRRC37A3	1461	O60309
PFNLTSEPSDYALDL	IER3	131	P46695
VSSDSFDPLLALYAP	LSM11	26	P83369
PPLIGSESAYESFLS	MAP1B	1401	P46821
ASDGLSNLPSPFAYL	MCTP2	181	Q6DN12
TVAEGESPSPAYLLF	MAGEB18	31	Q96M61
LSAGPYRGTLFADQP	MCPH1	746	Q8NEM0
SEYTPDLLPNGADFK	EYS	2556	Q5T1H1
DPLSASLGLQLVDPY	nan	71	A8MVJ9
FNYPLLSSPGDQFEI	LRRC37A2	1461	A6NM11
FNYPLLSSPGDQFEI	LRRC37A	1461	A6NMS7
GYCASLFAILLPQDP	LGALS3BP	241	Q08380
TPSFLNFYPLGEDID	NLRC4	111	Q9NPP4
LPNYLFPASEPDALN	ELF4	131	Q99607
LDYLALDFNSASPAP	GAB3	531	Q8WWW8
DFGANIYLPSLSLDL	ASB12	236	Q8WXK4
DDLATSLVLDPYLGF	KMT5B	81	Q4FZB7
PDSQITLYGPLLNAF	KIAA1109	731	Q2LD37
AFLEPLGLAYTGPDN	LENG8	771	Q96PV6
PLSAAKNEELLSPGY	FANCM	1311	Q8IYD8
LTSRFADGLPPFNYS	LMLN	296	Q96KR4
IADDLPHPFGLTQYS	LRP5	841	O75197
NPFPDYEAAAGALLA	LANCL2	26	Q9NS86
ALALGPSEYDSLPEN	LARP4B	126	Q92615
ALLPNFFVGSLEYDP	MTNR1B	171	P49286
LPPVCGDFLLDYSLD	CCDC120	436	Q96HB5
ADHDYPPGLLIAFSA	ORAI1	111	Q96D31
TDLPLLGPNYFVNES	DSG4	866	Q86SJ6
IDANSPLYDLAPSDL	KCNJ11	261	Q14654
FLYLSDNLLDSIPGP	OPTC	251	Q9UBM4
LDGNPINLSLFPSAY	OPTC	306	Q9UBM4
SDPGLTAPLYFFLGN	OR4N2	51	Q8NGD1
SDPGLTAPLYLFLGN	OR4N4	51	Q8N0Y3
SDPGLTAPLYFFLGN	OR4N5	51	Q8IXE1
ALSLPAESYGNDPDI	PBDC1	21	Q9BVG4
TGNLYLLSRAFVPPD	PNPLA3	216	Q9NST1
PTPGYFTDDQTLDFL	FAM234B	431	A2RU67
YIQSLPSLDNPEVFG	DNAH8	4166	Q96JB1
SGALAYPLAAFPAAA	HMX1	321	Q9NP08
FPLEGPYAAATATAV	NOTCH3	2121	Q9UM47
SAALALYGPPLDAVL	NAXD	21	Q8IW45
LSLFGDPYELDPFDS	PHRF1	431	Q9P1Y6
FATPDYTPELEAGNL	MYCLP1	121	P12525
DPLELVATGFYAEPT	LILRB5	111	O75023
VPSASDFQPLRYLDG	GLIS2	111	Q9BZE0
DFQPLRYLDGVPSSF	GLIS2	116	Q9BZE0
ARQGPDAYTDFFLPL	NFKBIL1	106	Q9UBC1
LSSYDGAPLLPFSSA	PTPRZ1	811	P23471
VSYQLLEAPDPSLFA	PCDHGC4	606	Q9Y5F7
LYETQAPENSPIGFL	PCDHB10	246	Q9UN67
VLDANDNSPFVLYPL	PCDHB10	551	Q9UN67
VLDANDNSPFVLYPL	PCDHB15	551	Q9Y5E8
AFQPGKLDEDPLLSY	PLEKHM3	391	Q6ZWE6
AYFSTPPAQRLALLG	MMACHC	221	Q9Y4U1
LAVNPFDGLPFSSRY	DQX1	21	Q8TE96
VLDANDNSPFVLYPL	PCDHB12	551	Q9Y5F1
VLDANDNSPFVLYPL	PCDHB11	551	Q9Y5F2
AENEPSAGLLSGYPF	GBA	271	P04062
NPCPLYDAQTGTLFL	NEU2	86	Q9Y3R4
VLDANDNSPFVLYPL	PCDHB16	551	Q9NRJ7
PCGAEPTAFLAQALY	FCHSD1	541	Q86WN1
VLDANDNSPFVLYPL	PCDHB14	551	Q9Y5E9
VLDANDNSPFVLYPL	PCDHB7	551	Q9Y5E2
TPYLESGISLFSDDP	BRCA1	1561	P38398
PNASLEAFLRAPEAY	GAL3ST3	176	Q96A11
PLGFNIPYEFTDGDL	DNAH1	3836	Q9P2D7
EYPKPDGQISFDLLS	ETFDH	506	Q16134
ILASFASSDDPYQGP	ATR	1096	Q13535
PNKDLGLEYLSPSND	CDHR2	1226	Q9BYE9
SALPARLLTSDFPYG	LINC01558	16	Q9Y6Z2
LESSYQADFRPGPGL	C3orf84	106	H3BNL1
RLSPTPADDYNFNLD	E2F5	316	Q15329
SPDLLGDPDNYTLAN	MT-CYB	246	P00156
VAGSAPPAQLLAYES	B3GNT4	161	Q9C0J1
LTPSGFTIFLNEYPA	CRTAM	51	O95727
PAFLPDPNDGSLYTL	ERN1	71	O75460
AYLDGVSLPDFELLS	DDIT4	71	Q9NX09
FLYASPDVSEPIDGL	CD36	346	P16671
GTLEASFPAPLYSDD	C19orf71	16	A6NCJ1
LQPGESYLFGSPSDI	POLQ	1766	O75417
SYADFVRGFLLPNLP	JMJD4	86	Q9H9V9
GPLETRDYPQNSLFD	IL23R	456	Q5VWK5
VYLLPSLNPDGFERA	CPD	176	O75976
YEATFLAADNGIPPA	CDH4	581	P55283
LGPLEAQDSLYNSPL	FAM131A	296	Q6UXB0
LAPGCLDAFPLLSAY	GSTP1	166	P09211
AGPSENDPNLFVALY	ABL1	56	P00519
SNGVLLPFYDPDSSI	CORO6	266	Q6QEF8
GLPDLVADPYYIQAS	LOX	211	P28300
RAPYSGPQDLAALLE	ANKS3	421	Q6ZW76
LSAAPFAQRYLGTLP	CEP192	1256	Q8TEP8
NPKASDSPIDLFYGD	GDA	401	Q9Y2T3
NPLSPLYSLDVLADA	GPATCH2L	371	Q9NWQ4
SYSEDPEPLLLAAGL	CUL9	2041	Q8IWT3
PLGPASFNLSEYFRQ	GDF9	331	O60383
SLLINPLQFPDEGNY	HEPACAM2	106	A8MVW5
ALADGDLSVPPYDAF	CDH22	756	Q9UJ99
EPGADLLYDVPSSQA	HELQ	186	Q8TDG4
NDLGPFYSLPSKVRD	HELQ	311	Q8TDG4
YTLPGAQDAKDDFPL	HDAC9	201	Q9UKV0
DDYPLASLPLLGYSV	FARP2	966	O94887
ALGAAQPDSLKPYAE	CAND2	921	O75155
ELPGQLPTLYDFHFD	DNAH10	2386	Q8IVF4
YLAASGLLPATAFPD	SLC15A3	111	Q8IY34
LAEPILPYALAFAAG	SLC39A11	286	Q8N1S5
LGTPSFAPYEANVDF	POLD1	236	P28340
SDLDDYLGFLPTFGP	DYSF	506	O75923
PLNSDGYPDSLALAN	DDB1	681	Q16531
QLPESFPSLLDDDGY	EPB41L3	591	Q9Y2J2
FPSLLDDDGYLSFPN	EPB41L3	596	Q9Y2J2
GLPLTNALENSLFYP	JADE3	521	Q92613
DPLSTPFDNEFYNGL	C9	166	P02748
LFDLDPETPANGYRS	LIPE	361	Q05469
KQGTALLLPSPEFDY	PRR14L	591	Q5THK1
ALDIDLLPGAASPYL	NYNRIN	1051	Q9P2P1
VLDANDNSPFVLYPL	PCDHB3	551	Q9Y5E6
SPAQLDPFYTQGDSL	NUP35	151	Q8NFH5
LVLDANDNSPFVLYP	PCDHB8	551	Q9UN66
VLDANDNSPFVLYPL	PCDHB9	551	Q9Y5E1
LEDLLCFQTPSYPLG	MOS	226	P00540
LDDLQASTYFGPTPV	MINAR1	331	Q9UPX6
LGYDPTAAAALSLPL	NR4A3	211	Q92570
YIVAAFNLSPADPDG	FER1L6	1361	Q2WGJ9
RFVEQLGSYDPLPNS	MRPS16	46	Q9Y3D3
TPSPFLRFYLDSGEQ	MRPS25	71	P82663
QAPIGLEATDFPLQY	RTL3	226	Q8N8U3
DLDPYGSPATFLDAA	TRMT1	231	Q9NXH9
DNSPEYSLFVGDLTP	TRNAU1AP	91	Q9NX07
YIDSSDYPLLPLNNF	SEZ6L	291	Q9BYH1
DAYGPPSNFLEIDIF	SNX12	21	Q9UMY4
EDLYSAPQPALFLVD	SVIL	2036	O95425
LFSDGSVTPLDIYDP	TMEM132B	706	Q14DG7
DANAAGLYFTLEPQP	SAMD5	66	Q5TGI4
LPEDGTATFFLPYLL	HPS3	981	Q969F9
YLELPDLGQPYSSAV	NBPF8	686	Q3BBV2
YLELPDLGQPYSSAV	NBPF9	721	P0DPF3
LELPDLGQPYSSAVY	NBPF9	891	P0DPF3
YLELPDLGQPYSSAV	NBPF10	721	Q6P3W6
LELPDLGQPYSSAVY	NBPF10	966	Q6P3W6
YLELPDLGQPYSSAV	NBPF10	1941	Q6P3W6
LELPDLGQPYSSAVY	NBPF10	2186	Q6P3W6
YLELPDLGQPYSSAV	NBPF10	3161	Q6P3W6
LELPDLGQPYSSAVY	NBPF10	3406	Q6P3W6
YLELPDLGQPYSSAV	NBPF14	381	Q5TI25
LELPDLGQPYSSAVY	NBPF14	701	Q5TI25
LELPDLGQPYSSAVY	NBPF15	451	Q8N660
LELPDLGQPYSSAVY	NBPF19	451	A0A087WUL8
YLELPDLGQPYSSAV	NBPF19	1426	A0A087WUL8
LELPDLGQPYSSAVY	NBPF19	1671	A0A087WUL8
YLELPDLGQPYSSAV	NBPF19	2646	A0A087WUL8
LELPDLGQPYSSAVY	NBPF19	2891	A0A087WUL8
YLELPDLGQPYSSAV	NBPF20	106	P0DPF2
LELPDLGQPYSSAVY	NBPF20	351	P0DPF2
YLELPDLGQPYSSAV	NBPF20	1326	P0DPF2
LELPDLGQPYSSAVY	NBPF20	1571	P0DPF2
YLELPDLGQPYSSAV	NBPF20	2546	P0DPF2
LELPDLGQPYSSAVY	NBPF20	2791	P0DPF2
YLELPDLGQPYSSAV	NBPF20	3766	P0DPF2
LELPDLGQPYSSAVY	NBPF20	4011	P0DPF2
YLELPDLGQPYSSAV	NBPF20	4986	P0DPF2
YLELPDLGQPYSSAV	NBPF26	681	B4DH59
TDLLSLPNVNPDAGY	SEC24A	771	O95486
YSLGLNDLNVSPPEL	JAML	16	Q86YT9
YLQSRAPPEGDSDLA	NBEAL2	346	Q6ZNJ1
SDPLGLAASQANFYP	PTCH2	866	Q9Y6C5
DQALPNDVLFSSTYP	SIPA1L1	1606	O43166
LLFYAADLNPDAEPF	SIMC1	851	Q8NDZ2
PYVFFASEGLLNTPD	SHOC1	866	Q5VXU9
FLYLLSAPREAPATG	SHARPIN	296	Q9H0F6
TFGAAVDPDVLLSYP	SLC38A7	301	Q9NVC3
ALYVNSFPLLDPSDA	TANK	336	Q92844
GLDPDNFSIPYLTAL	SLC41A1	471	Q8IVJ1
PESNAEYLASLFPDS	STEAP2	126	Q8NFT2
LGLLQTYFREDPDTP	NSMCE4A	271	Q9NXX6
AEGLFSTLPFPVYSN	NPAS3	906	Q8IXF0
GSIELEFYLAPEPFS	RNF217	221	Q8TC41
SLAPSLLAAALEGPY	SCRIB	986	Q14160
ALNLDPVQLTFYAGP	ITGA2B	31	P08514
RLLSSGFEEVYPNLP	RANBP6	76	O60518
DQAESPTFPYLNTLL	DIS3	726	Q9Y2L1
LENSDASLGPLAYQP	SMARCC1	671	Q92922
DPYLEDSEASLGPLA	SMARCC2	646	Q8TAQ2
GLNFSAPEQPLSLYE	PLA2R1	91	Q13018
ALSEGQFYSPPESFA	STARD3	201	Q14849
FYGSLIAELPSSTPA	ROBO4	581	Q8WZ75
GFPAYELDPSHLLAS	SMCR8	646	Q8TEV9
TFPSDVPYQAALGTL	SH3RF1	381	Q7Z6J0
SLYSLAGNPVDPLAQ	SREBF1	786	P36956
FLDVGEYNSALPLLS	GTF3C3	431	Q9Y5Q9
TNFDPRGLLPESLDY	CA2	176	P00918
SYFLLLTSPEAQDPG	CLN3	226	Q13286
QPSASPLEGLLDLSY	CMTM7	26	Q96FZ5
DLYNASPEPKTLFLG	CLSPN	841	Q9HAW4
FQPLLLFYANPDGTA	USP53	341	Q70EK8
ALGRLYPPEQSLTAF	ZNF750	441	Q32MQ0
SFSNYRPFEPQALGL	SEPHS2	31	Q99611
PLTEYNIDVDLPGSF	TTC13	446	Q8NBP0
SDPGLLTALYGPDFT	TNFAIP8L2	151	Q6P589
PLSYVPNDLLGFSDA	UGT1A10	186	Q9HAW8
TESSPDFTLPGDYLL	TAS1R1	26	Q7RTX1
DFTLPGDYLLAGLFP	TAS1R1	31	Q7RTX1
LADDYTPAPAAFQGL	ZFHX2	421	Q9C0A1
SSAVPLLLSYFQGPE	RBP3	486	P10745
GFSILDYQDPIDPAS	MPDZ	711	O75970
AAFYLALSADVPPAL	NOD2	611	Q9HC29
YCSLGPDSLLPNIFF	SNX14	66	Q9Y5W7
FYLDIQPSPDQSGLD	RORA	221	P35398
GDAYPAPFTSTNGLL	SP7	61	Q8TDD2
LGFSILDYQDPLDPT	PATJ	696	Q8NI35
SRSLYPDAEDPQLGL	PSD2	111	Q9BQI7
LSAIAGALPPDYLDT	RYR3	2566	Q15413
SADGPLKLLPESYFD	IGHMBP2	356	P38935
YEAFNRLLAPGVDPS	SPDYE3	101	A6NKU9
EPYNKGRLSALPFAD	STAT4	626	Q14765
PDSLLAYLEQAGASP	VPS18	676	Q9P253
FPDYLEAIPGTNVDL	YAP1	441	P46937
ATISAEAFYPDLGPE	ZNF710	36	Q8N1W2
EAFYPDLGPELSGAA	ZNF710	41	Q8N1W2
SPSPELIDLYQKFGF	TEX264	106	Q9Y6I9
GAAYLESLPLQDASP	TNFRSF8	476	P28908
SFANYLVGTLIPPSE	SLC12A3	296	P55017
EGLEPYALFNLSVTP	ROS1	1006	P08922
GLDAPDCLPYDSLSF	TTLL2	446	Q9BWV7
AYGPPSNFLEIDVSN	SNX3	21	O60493
YPAAAGDPASLDFAQ	TOX3	6	O15405
LPGLTSFPDLYANFL	RPAP1	1201	Q9BWH6
PNSTLPEGFELYSQL	RPAP1	1356	Q9BWH6
PVLFGEDPLDSYLNF	nan	71	Q6ZUG5
AGVPDFLPSAQRALY	ZC3H4	756	Q9UPT8
YELLASLGPAAAKPD	ZNF862	366	O60290
FDPPLYGSLSANRDS	ZNF469	1436	Q96JG9
PSLLDPDQDATYFGA	TNFSF11	296	O14788
AELSLESGADLPYLP	SYCN	56	Q0VAF6
LDLPELQPAAFVSSY	TBRG1	366	Q3YBR2
LYFLSPQENRPSLFG	USP6	886	P35125
SPPAFDGELDLQRYS	ZNF219	16	Q9P2Y4
PSNAYGLPESEFLIV	TBK1	101	Q9UHD2
YQLLSENPPDGERFS	THOC1	361	Q96FV9
LSYFDEGRTLPAPFN	TRPC7	696	Q9HCX4
NDEFFTSGYIPARLP	PLK1	301	P53350
AEKSPGAYFLPEFAL	ADAMTSL3	26	P82987
PGADYDLCLLALSPA	LRFN4	466	Q6PJG9
LPLGLAPDTFDDTYV	ART5	26	Q96L15
PTGLFYLLDEESNFP	MYO9B	586	Q13459
ALATPSAPYGFALLN	MYOM3	696	Q5VTT5